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Abstract 
Introduction: 
The primary objective was to determine whether pregnant women visiting primary 
health care clinics (PHCs) were aware of the nutritional supplementation 
programmes: Nutrition Supplementation Programme (NSP) food, folate-, iron- and 
vitamin A supplementation. The secondary objective was to determine whether 
pregnant women qualified for the NSP food-, folate- and iron supplementation. The 
third objective was to determine whether those who qualified received the 
prescribed NSP food-, folate-, and iron supplementation and whether they were 
compliant with these interventions.  
Design: 
A cross-sectional descriptive study was conducted at all PHCs hosting basic 
antenatal clinics in the Cape Town Metropolitan Area of the Western Cape 
Province, South Africa.   
Method: 
One hundred and fourteen pregnant women who met the inclusion criteria were 
included in the study using a non-random quota sampling strategy. Pregnant 
women were interviewed using a validated questionnaire. The mid upper arm 
circumference (MUAC) was measured and the symphysis-fundus (SF) 
measurement was obtained from the medical files to determine whether 
participants met the entry criteria for the NSP. Written informed consent was 
obtained from participants. 
Results: 
Fifty per cent of participants were between 12 and 24 weeks of gestation. Most of 
them (68%) had an MUAC of between 24,7 cm and 34,4 cm. Fifty (44%) of the 
participants had a sufficient SF measurement. Twenty-one (18%) of the 
participants indicated that they were aware of the vitamin A Programme, 56 (49%) 
were aware of the NSP food-supplementation and 79 (70%) knew about the folic- 
and iron supplementation that pregnant women should receive from the clinic. Six 
(5%) participants qualified for the NSP with an MUAC of below 23 cm. Only one 
(17%) participant was registered with the NSP and received the food- 
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supplementation. Seventy (61%) of the participants indicated that they received 
and used the iron- and folic supplements, of which 30 (43%) did not know why 
they needed to take these supplements.  
Conclusion:  
Folate- and iron supplementation appears to be reasonably successfully 
implemented in the Cape Town Metropolitan Area among pregnant women visiting 
PHCs. The NSP food-supplementation, however, appears to be unsuccessfully 
implemented and needs further attention. Resources could be appointed to inform 
pregnant women about the reasons for and importance of taking these 
supplements.  
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Opsomming 
Inleiding: 
Die hoofdoelstelling was om te bepaal of swanger vroue wat primêre 
gesondheidsorgklinieke (PGK’s) bywoon, bewus was van die voeding 
supplementasie programme: Voedsel Supplementasie Program (VSP) – 
voedselaanvulling, folaat-, yster- en vitamien A supplementasie. Die tweede 
doelstelling was om te bepaal of hierdie swanger vroue in aanmerking kom vir die 
VSP– voedselaanvulling, folaat- en yster supplementasie. Die derde doelstelling 
was om te bepaal of hierdie swanger vroue die voorgeskrewe VSP – 
voedselaanvulling, folaat- en yster supplementasie ontvang het en hierdie 
intervensies nagevolg het. 
Ontwerp:  
ŉ Deursnit beskrywende studie is gedoen en data is ingesamel van al die PGK’s 
wat voorgeboortelike klinieke huisves in die Kaapstadse metropolitaanse gebied, 
in die Wes-Kaapprovinsie, Suid-Afrika. 
Metode: 
Honderd en veertien swanger vroue wat aan die insluitingskriteria voldoen het, is 
volgens ŉ nie-ewekansige kwotastrategie uitgesoek om aan die studie deel te 
neem. Onderhoude is volgens ŉ bevestigde vraelys met swanger vroue gevoer. 
Die omtrek van die middelboarm is geneem en die symphysis-fundus-meting is 
van die mediese lêers verkry om te bepaal of deelnemers aan die 
insluitingskriteria vir die VSP voldoen. Deelnemers het ŉ vrywaringsvorm geteken 
voordat hulle aan die studie begin deelneem het.  
Resultate: 
Vyftig persent van die swanger vroue het ŉ gestasie-ouderdom van tussen 12 en 
24 weke gehad. Die omtrek van die meeste vroue (68%) se middelboarm was 
tussen 24,7 cm en 34,4 cm. Vyftig (44%) van die vroue se symphysis-fundus-
meting was voldoende. Een en twintig (18%) van die deelnemers het aangedui dat 
hulle van die Vitamien A-program bewus was, 56 (49%) was van die VSP-
voedselaanvulling bewus en 79 (70%) van die deelnemers was bewus van die 
folaat- en yster supplementasie wat swanger vroue van die kliniek behoort te 
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ontvang. Ses (5%) deelnemers, met ŉ middelboarm-omtrek van minder as 23 cm, 
het vir die VSP in aanmerking gekom. Slegs een (17%) deelnemer was 
geregistreer en het die voedselaanvulling ontvang. Sewentig (61%) van die 
deelnemers het aangedui dat hul wel yster- en folaat supplementasie ontvang en 
gebruik, waarvan 30 (43%) nie geweet het waarom hulle dié supplemente neem 
nie.   
Gevolgtrekking: 
Dit wil voorkom asof folaat- en yster supplementasie vir swanger vroue wat PGK’s 
in die Kaapstadse metropolitaanse gebied besoek, redelik suksesvol toegepas 
word. Daarteenoor word die VSP – voedselaanvulling onsuksesvol uitgevoer en 
behoort dit verdere aandag te geniet. Hulpbronne kan aangewys word om 
swanger vroue beter in te lig oor die doel en belangrikheid daarvan om hierdie 
supplemente te neem.   
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List of definitions 
Antenatal:  The period of time before birth.1 
Body mass index:  Weight in kilograms divided by the square of 
height in meters; body mass indexes of 20–24,9 
kg/m2 are considered normal.1 
Blastogenesis: The transformation of lymphocytes into larger 
cells capable of undergoing mitosis.2 
Conception:  The fecundation of the ovum.3 
Deaf-mutism: Lacking the sense of hearing and the ability to  
 speak.2 
Diplegia: Paralysis of corresponding parts (as the legs) on  
 both sides of the body.2 
Dysarthria: Difficulty in articulating words due to disease of  
 the central nervous system.2 
Ectopic pregnancy: Gestation elsewhere than in the uterus (as in a  
 fallopian tube or in the peritoneal cavity).2 
Foetus:  The human child in utero after completion of the 
eighth gestational week.4 
First term:  See first trimester.   
First trimester:  The first three months of pregnancy.4 
Fortification:  The process of adding nutritive substances not 
naturally occurring in the given food to increase 
its nutritional value.5 
Gestation:  The time from fertilisation of the ovum until birth; 
in humans, the length of gestation is usually 38–
42 weeks.5 
Infant:  Birth to one year of age.1 
Intrauterine: Within the uterus.3 
In utero:  See intrauterine.  
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Late gestation:  See late term.   
Late term:  Occurring or performed after the 20th week of 
gestation in humans.3 
Low birth weight:  A birth weight of less than 2 500 g (5,5 lb).1 
Low prepregnancy weight:  A woman with a BMI less than 20 kg/m2 before 
becoming pregnant.1 
Malnutrition:   A condition that develops due to inadequate or  
     unbalanced intake of nutrients or their impaired  
     assimilation or utilisation.4 
Maternal:  Pertaining to the mother.3 
Neonate:  A newborn infant.3 
Neural tube defect(s):  A defect resulting from failure of the neural tube 
to close during the fourth week of 
embryogenesis; related to folic acid deficiency.1 
Nutrition supplementation: Nutrients taken in addition to normal food and 
drink to supplement the nutritional needs of the 
body.4 
Periconception:  Relating to the period from before conception to 
early pregnancy.4 
Perinatal:  From 28 weeks of gestation to four weeks after 
birth.1 
Perinatal mortality:  The number of infant deaths occurring in the 
period that extends from 28 weeks’ gestation to 
four weeks after birth.1 
Placental abruption: Premature detachment of the placenta from the 
wall of the uterus.2 
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Placenta praevia: An abnormal implantation of the placenta at or 
near the internal opening of the uterine cervix so 
that it tends to precede the child at birth, causing 
severe maternal haemorrhage.2 
Premature:  See preterm.   
Preterm:  An infant born prior to the 37th week of gestation; 
also referred to as a premature infant.4 
Quadriplegia: Paralysis of all four limbs; also called 
tetraplegia.2 
Second term:  See second trimester.   
Second trimester:  The middle three months of pregnancy.4 
Supplement:  Something that completes or makes an 
addition.4 
Symphysis-fundus  The distance from the junction of the pubic 
measurement:  bones on midline in front to the uppermost part 
 of the uterus.6 
Term infant:  One born from the beginning of the 38th week 
through the 42nd week of gestation.5 
Third term:  See third trimester.   
Third trimester:  The third and final three months of pregnancy.4 
Trimester: Any of three periods of approximately three 
months each into which a human pregnancy is 
divided.4 
Undernutrition:  The state that results from a deficiency of one or 
more nutrients.5 
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1.1 INTRODUCTION 
Pregnancy nutrition plays an important role in the development of the foetus and 
the newborn infant’s weight as well as long-term health risks for the infant.1 During 
World War 2, famine was rife and undernutrition among pregnant women had 
deleterious effects on the health of their newborn babies and also on the health of 
these children later in life.1–7 Exposure to famine during any stage of gestation was 
associated with glucose intolerance in adults aged 50 to 58 years,7,8whereas those 
infants exposed to famine in early gestation was associated with more coronary 
heart disease, a more atherogenic lipid profile, disturbed blood coagulation, 
increased stress responses and more obesity in later life.7 Infants exposed to 
famine during mid gestation had more microalbuminuria and obstructive airway 
disease.7 These findings show that maternal undernutrition during gestation has 
important effects on health in later life; especially early gestation seems to be a 
vulnerable period.7 
 
The key components of the American Dietetic Association guidelines for a healthy 
lifestyle during pregnancy include, among other things, appropriate weight gain, 
consumption of a variety of foods and appropriate and timely vitamin and mineral 
supplementation.9 
 
1.2 NUTRITIONAL REQUIREMENTS DURING PREGNANCY 
1.2.1 Energy 
Due to the metabolic demands of pregnancy and foetal growth, additional energy 
is required.1 Unlike the popular belief that the foetus can protect itself by 
parasitising the mother, the opposite is true.1 Unbalanced diets during pregnancy, 
particularly with respect to protein and carbohydrates, have been linked to adverse 
pregnancy outcomes, including low birth weight (LBW).9Table 1.1 gives a 
summary of the appropriate energy, protein and carbohydrate intake for pregnant 
women according to the different trimesters.   
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Table 1.1: Recommended energy, protein and carbohydrate intake for 
different trimesters during pregnancy.1,5,9,10 
Macronutrients First  
trimester 
Second  
trimester 
Third  
trimester 
Energy (kcal/d) (+) 300  (+) 340–350  (+) 452–500  
Protein (g/d) 60–71  60–80 60–84 
Carbohydrates 
(g/d) 
100–175  100–175  100–175 
(+) Additional to the recommended intake for healthy nonpregnant women. 
 
1.2.2 Protein 
Protein is required to build foetal tissue as well as the tissue of the pregnant 
mother: blood volume increases, breasts develop and the uterus enlarges and fills 
with a sac containing amniotic fluid.5 For these reasons, protein intake for pregnant 
women is 71 g/d (compared to the 46 g/d for nonpregnant women).5 
 
1.2.3 Micronutrients 
1.2.3.1 Vitamin A 
The recommended dietary allowance (RDA) of 4 000 IU/800 RE for vitamin A is 
not increased for pregnancy in view of maternal stores that easily meet foetal 
accretion rate. At least seven case reports of adverse pregnancy outcome have 
been associated with a daily ingestion of 25 000 IU/7 500 RE or more. In addition, 
epidemiological evidence indicates that the drug isotretinoin, a vitamin A analogue 
used for treatment of cystic acne, causes major malformations involving 
craniofacial, central nervous system, cardiac and thymic changes. These findings 
do not apply to β-carotene, a precursor of vitamin A. Vitamin A poses the most 
danger when taken in high amounts two weeks prior to conception and during the 
first two months of gestation.1 Placental transport of vitamin A between mother and 
foetus is substantial, and recommended intakes are increased by 10% in 
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communities at risk for vitamin A deficiencies. Low maternal vitamin A status is 
inconsistently associated with intrauterine growth retardation in these 
communities. Diet supplementation with 7 000 µg RE vitamin A or 42 mg β-
carotene is reported to reduce maternal mortality by 40% and 49%, respectively, 
but does not affect foetal loss or infant mortality rates.11 Zinc supplementation 
during pregnancy improves vitamin A status of mothers and infants postpartum.12 
 
1.2.3.2 Folic acid 
Folate functions as a coenzyme in the metabolism of nucleic and amino acids1; 
therefore, during periods of enhanced anabolic activity (such as pregnancy),13 
folate requirements are increased.1,14 A deficiency in folic acid is marked by a 
reduced rate of DNA synthesis and mitotic activity in individual cells. Clinical 
detection of megaloblastic anaemia may not occur until the third trimester. 
Maternal folic acid deficiency is associated with an increased incidence of 
pregnancy-related problems, including congenital malformations in the offspring.1 
 
Neural tube defects (NTDs) account for most congenital anomalies of the central 
nervous system and result from failure of the neural tube to close spontaneously 
between the third and fourth week of in utero development.1 Normally, the rosral 
end of the neural tube closes on the 23rd day and the caudal neuropone closes by 
a process of secondary neurulation by the 27th day of development, before the 
time that many women realise that they are pregnant.1,15NTDs have a fairly high 
recurrence rate of 2–10% worldwide.1 In South Africa the prevalence of NTDs was 
found to be 0,98 per 1 000 births in a study done among 12 public hospitals in four 
provinces.16 The Lancet series on Maternal and Child Undernutrition,17 the World 
Health Organization (WHO) publication on Prevention of Neural Tube Defects18,19 
and the United Nations Children’s Fund (UNICEF)20 state and support findings that 
between 50% and 80% of NTDs can be prevented by the consumption of folic acid 
by women before and during early pregnancy.15,21 Red cell folate levels exceeding 
906 mmol/l are best for preventing NTDs.1 Since the neural tube closes by 28 days 
of gestation, folic acid supplementation should be initiated before conception and 
continued until at least 12 weeks of gestation when neuralation is complete.1,15  
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Women planning a pregnancy should begin periconceptional supplementation with 
folic acid at levels 400–800 ug/d.1,9The Institute of Medicine (United States of 
America) recommends 400 ug/d folic acid in addition to normal dietary intake to 
reduce the risk of NTDs.22Women of childbearing age should be encouraged to 
include a generous amount of folic acid sources in their diets – dark green, leafy 
vegetables, legumes, orange juice, soy, wheat germ, almonds and peanuts.1 
Women with a folate intake of 240 µg/d or less were found to have double the risk 
of bearing a LBW or premature infant,1,23 especially when the deficiency occurred 
during the second and third trimester of pregnancy.24 Mothers following a prudent 
eating pattern (high in fish, garlic, nuts and vegetables) had increased vitamin B12 
and serum folate levels and a lower risk of cleft lip/palate in their offspring 
compared to mothers following a Western diet (high in meat, fat and refined 
carbohydrates and low in fruit).25 
 
However, folic acid supplements are believed to be more bioavailable than food 
folate.26 In a study done among late pregnant and lactating women, it was found 
that one third of highly educated women did not meet their folate requirements 
from diet alone. Without fortification, 98% of this sample would not have met their 
folate requirements from dietary sources.14 An extensive study on the effects of 
folic acid fortification reported a 19% drop in the rate of NTDs in the United States 
of America.27 Data from the National Health and Nutrition Examination Survey 
before and after food fortification suggest that serum and red blood cell folate 
concentrations have increased by 153% and 63%, respectively.14 Food fortification 
with folate was also associated with significant decreases in the prevalence of 
spina bifida among non-Hispanic white (34%) and Hispanic (36%) births.28 
 
In Ethiopia 46% of women of childbearing age had a severe folate deficiency (< 4 
ng/ml), 21% had a marginal deficiency (4–6,6 ng/ml) and 33% had an optimal level 
(> 6,6 ng/ml).29 The study suggested that folate deficiency in Ethiopia was related 
to diet, since the risk of women of childbearing age to develop folate deficiency 
was 0,9 times lower among those who consumed grain and vegetables more than 
once a day.  
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According to a study in Vancouver, Canada, 95% of women had heard of folate 
but only 25% knew that it could prevent birth defects.30 The most common sources 
of information on folate were magazines, newspapers, doctors, television and 
radio. Lack of awareness of the importance of folate was the most common reason 
given for choosing not to use folic acid supplementation before pregnancy. 
Seventy-eight per cent of the women indicated that with knowledge of the benefits 
of folate, they would have used supplemental folic acid daily to reduce the risk of 
birth defects.30 
 
In South Africa the findings of the National Food Consumption Survey of 1999 
identified, among other parameters, the foods most commonly consumed in the 
country by type and amount31 and paved the way for the statutory fortification of 
maize and wheat products. The legislation was enacted in April 2003 and 
implemented in October 2003.32 Nutrients added to maize meal and wheat flour 
included folic acid as part of the six vitamins that were added. Other nutrients that 
were added were vitamin A, B1, B2 and B6, niacin, iron and zinc.32,33 
 
A study conducted in the Limpopo Province in South Africa showed a significant 
improvement in folate status in women of childbearing age approximately nine 
months after this fortification of maize and wheat products had been introduced in 
South Africa.34 The prevalence of low serum folate (< 3 ng/ml) in the study 
population was 28% before fortification; after fortification, none of the women had 
low serum folate. Low red cell folate (< 164 ng/ml) was observed in 26% of 
subjects before fortification and in 2% of subjects after fortification. In another 
study done in the Limpopo Province, folate deficiency based on red cell folate and 
serum folate was present in 5% and 10% of pregnant women, respectively. The 
authors explained this improvement of folate levels, compared with previous 
studies done in the same province, as a result of the folate supplementation by the 
Department of Health.35,36 A study that involved 12 provincial hospitals was also 
done in South Africa to measure the change in prevalence of NTDs before and 
after the implementation of the food fortification legislation. This study showed a 
significant decline of 30,5% in NTDs.16 
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The National Food Consumption Survey Fortification Baseline (NFCS-FB-I) study 
was conducted in 2005 in South Africa.37 The panel summarised its findings as 
follows: 1) The status of folic acid, according to mean serum and red blood cell 
folate, appeared to be adequate throughout the country. 2) Higher serum and red 
blood folate concentrations were noted among respondents from provinces where 
there was a better consumption of green leafy vegetables. 3) This could be the first 
indication that the food fortification programme was associated with a beneficial 
outcome. These findings of the NFCS-FB-1 support the findings of the Limpopo 
Province studies and correlate well with the finding of a reduction in the prevalence 
of NTDs. 
 
1.2.3.3 Vitamin B12 
Vitamin B12 is required for a series of reactions that precede the role of folic acid in 
DNA replication.1 Without vitamin B12 folic acid is unable to assist in the 
manufacturing of red blood cells.3,38 Vitamin B12 is also essential for the synthesis 
and maintenance of myelin, the substance that permits speedy transmission of 
impulses along the nerves. Vitamin B12 requirement is therefore slightly raised 
during pregnancy to 2,6 mg/d.5 Vegetarians particularly should be informed of the 
cobalamin content of their food because neurological impairment has occurred in 
their infants.5 
 
1.2.3.4 Vitamin C 
Increased amounts of vitamin C are needed during pregnancy.5 Vitamin C 
converts folic acid into its active form, enhances the absorption of iron and helps to 
form connective tissues. Women who have been using oral contraceptives have 
been found to have lower levels of vitamin C, among other nutrients, that may take 
four months to return to normal after the drugs have been discontinued. Early 
signs of vitamin C deficiency are tender sore gums that bleed easily and small skin 
haemorrhages due to weakened blood vessels.5 Pregnant women with low vitamin 
C levels has a risk of prolonged rupture of membranes and amnionitis, which are 
both common causes of preterm delivery.38 The dietary reference intake for vitamin 
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C during pregnancy ranges between 80 and 85 mg/d, compared to the 60 mg/d for 
nonpregnant women.39 
1.2.3.5 Calcium 
Calcium is the chief mineral in the adult body, with the bones serving as a storage 
depot. When serum calcium is low, the bones demineralise to restore the serum 
level. However, no long-term detrimental effect of pregnancy on bone mineral 
measure was found in a study of 2 516 twins. Intestinal absorption of calcium 
increases during pregnancy. In a longitudinal study, it was found that the average 
proportion of calcium absorbed increased from 33% at prepregnancy to 50% 
during the second trimester and to 54% during the third trimester. One reason for 
this increased absorption is the ability of the placenta to convert inactive vitamin D 
to the active form. The adequate intake for calcium for pregnant women 19 years 
and older is 1 000 mg/d. For pregnant women 18 years and younger, the adequate 
intake is 1 300 mg/d.5 
 
1.2.3.6 Phosphorus and magnesium 
In addition to calcium, two other minerals involved in skeletal formation are also in 
great demand during pregnancy: phosphorus and magnesium.5 The RDA for 
phosphorus is 1 250 mg/d for pregnant women 19 years and younger and 700 
mg/d for pregnant women 19–50 years.5 The RDA for magnesium is 350 to 400 
mg/d for pregnant women.    
 
1.2.3.7 Iron 
A marked increase in the maternal blood supply during pregnancy greatly 
increases the demand for iron.1 With the availability of this mineral, total 
erythrocyte volume increases by 20–30%. Active bone marrow may utilise an extra 
500 mg of elemental iron during pregnancy, and the term foetus and placenta 
accumulate 250–300 mg of elemental iron. A pregnant woman must have between 
700 and 800 mg of extra iron, most of which is needed during the last half of 
pregnancy. Averaged over the entire pregnancy, this amounts to a daily increment 
of 15 mg iron. Adding this to the recommended intake of 15 mg/d for nonpregnant 
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women, it brings the recommendation for pregnant women to 27–30 
mg/d.1,9Women rarely enter pregnancy with sufficient iron stores to cover extra 
needs; therefore, iron supplementation (usually in a ferrous salt form) is often 
acknowledged as a necessary means of preventing iron deficiency anaemia. 
Maternal anaemia is defined as a haematocrit value < 32% and a haemoglobin 
level < 11 g/dl.1 Elevated maternal haemoglobin levels (> 13 g/dl) have been 
associated with increased foetal risk as well as increased maternal hypertension, 
possibly reflecting a failure in plasma volume expansion or the harmful effect of 
high haemoglobin levels on utero-placental circulation. Maternal anaemia is 
associated with perinatal maternal and infant mortality and premature 
delivery,40impaired mother-infant interaction,9 muscle dysfunction and lower 
physical capacity.41 
 
In a randomised controlled trial, it was found that maternal iron supplementation 
from enrolment to 28 weeks of gestation led to a significantly higher mean birth 
weight (increased birth weight by 206 g), a significantly lower incidence of LBW 
infants and a significantly lower incidence of preterm LBW infants when compared 
with a placebo.42 
 
According to the 1999 National Nutrition Survey in Mexico, the prevalence of 
anaemia was 27% among pregnant women. Women maintained sufficient iron 
stores during the first 16 weeks, but from there on there was a substantial 
reduction, especially at 28 weeks of gestation.43 
 
In South African studies, anaemia has been diagnosed in 7–29% of pregnant 
women. In the Limpopo Province, low haemoglobin levels were present in 8% of 
the women before fortification with iron and in 5% of the women after fortification.34 
Iron deficiency was present in 51% of participants in another study done in the 
Limpopo Province; 26% were severely iron depleted (ferritin levels < 12 ug/ml) and 
25% were moderately depleted (ferritin levels between 12 and 20 
ug/ml).35,36Mothers who were students had an 11,43 higher risk of being anaemic 
than those who were not students. For those who were unemployed, the risk was 
8,43 compared with those who were employed.35 The South African NFCS-FB-I 
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found that a third of women were anaemic on the basis of haemoglobin 
concentration and that a fifth of women had a poor iron status.37 In other parts of 
sub-Saharan Africa, the prevalence of anaemia among pregnant women ranges 
from 22% in Kenya to 69% in Malawi.35 
 
For optimal absorption, iron supplements should be taken between meals, not with 
milk, tea or coffee.1 If iron deficiency anaemia is detected, therapy should consist 
of 60–120 mg ferrous iron in divided doses throughout the day.1,9 When 
haemoglobin returns to the appropriate level for pregnancy, a regimen of 30 mg/d 
may be resumed.1 
 
1.2.3.8 Iodine 
As part of thyroid hormones, iodine is essential to the control of metabolism. The 
thyroid gland secretes thyroxine (T4) and triiodothyronine (T3) in response to the 
thyroid-stimulating hormone from the anterior pituitary gland. Both T3 and T4 
increase the oxidation rate in cells, thereby increasing metabolism. During the 
second half of pregnancy, resting energy expenditure increases by 23%.5The RDA 
for iodine for pregnant women is 175–220 µg.1,5 For deficiencies in countries where 
cretinism is endemic, supplementation is recommended. Cretinism is a congenital 
condition present at birth,5 characterised by mental deficiency, spastic diplegia or 
quadriplegia, deaf mutism, dysarthria, short stature and hypothyroidism.1 In South 
Africa it was found during the NFCS-FB-I that, based on the median urinary iodine 
of women and children, iodine deficiency disorders had been virtually eliminated. 
In the Northern Cape Province, urinary iodine was found to be in the excessive 
category of iodine status and further investigations were recommended.37 In the 
light of these findings, iodine supplementation (excluding table salt and iodine 
found in water) is not recommended to pregnant women in South Africa.   
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1.3 ADVERSE CONSEQUENCES OF MATERNAL MALNUTRITION 
1.3.1 Perinatal mortality and birth weight 
The birth weight of infants correlates better with perinatal mortality than with the 
length of gestation; therefore, the aim should be to decrease the incidence of LBW 
deliveries in order to decrease mortality rates.1 LBW also leads to an increased 
risk of adult non-insulin-dependent diabetes mellitus (NIDDM) and features of the 
insulin resistance syndrome44 as well as the development of chronic heart disease 
in adult life.45 
 
A study in South Africa investigated infant mortality rate inequalities in the Western 
Cape Province. The most common defined cause of death in all areas (except 
rural farm areas) was LBW.46 The Saving Babies 2003 Report reported a LBW rate 
of 15,4% for South Africa and 19,8% for the Western Cape Province.47 In the Cape 
Town Metropolitan Area, the LBW rate was 15,2% in 2005.48 The occurrence of 
LBW deliveries decreased to 13,1% in South Africa and 15,7% for the Western 
Cape Province in 2010.49 
 
Inadequate maternal weight gain during pregnancy is associated with a 
significantly lower infant birth weight.1,50 Correlation between infant birth weight 
and prepregnancy body mass index (BMI) showed conflicting results. For example, 
one study found no correlation between prepregnancy weight and infant birth 
weight50 while other studies reported that a low prepregnancy weight has a 
negative influence on infant birth weight.1,5,10,36 Maternal weight gain supports the 
products of conception (foetus, placenta and amniotic fluid) and maternal accretion 
of tissue (expansion of blood volume and extracellular fluid, uterine and mammary 
glands and maternal fat stores).9 Low maternal weight at delivery is associated 
with preterm labour, LBW and prematurity.51 
 
Epidemiological studies have shown that both small size and thinness of infants at 
birth are related to later disease in life (e.g. chronic heart disease and diabetes 
mellitus). In a study of over 15 000 men and women born between 1911 and 1930, 
death rates from chronic heart disease fell progressively between those who 
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weighed less than 2,5 kg at birth and those who weighed 4,3 kg;52,53 thus, the 
lower the birth weight below 2,5 kg, the greater the chance of developing a chronic 
heart disease. There was also a steep fall in the prevalence of glucose tolerance 
or NIDDM between men who were small and those who were large at birth.54 
Moreover, it is thinness at birth and not simply small size that is associated with 
the insulin resistance syndrome, which includes impaired glucose tolerance, raised 
blood pressure and disturbed lipid metabolism, in later life.55 It has been suggested 
that undernutrition in mid to late gestation alters the normal pattern of muscle 
development, leading to modifications in muscle metabolism and insulin 
resistance.8,56 A proposed mechanism for this alteration in muscle development is 
that poor foetal and infant nutrition has an effect on nuclear steroid/thyroid 
hormone receptors, such as sarcolemmal growth hormone receptor, janus kinase 
2 phosphorylation and insulin-like growth factors, glucose transporters myosins 
and glycolytic enzymes. This effect causes impaired cellular growth and 
metabolism (e.g. vascularisation and glucose sensitivity) together with insulin 
resistance, NIDDM and cardiovascular disease.56 
 
The most extensive, consistent and persuasive data relate to the association 
between LBW and high blood pressure.57 It was found in all ages and populations 
studied that as blood pressure increased, birth weight tended to decrease.58 
 
It has been speculated that LBW contributes to renal disease among the 
Aborigines in Australia’s Northern Territory. The researchers thought that the 
association might be mediated through impaired nephrogenesis caused by 
intrauterine malnutrition.59 
 
1.4 CONSEQUENCES OF NONNUTRITIONAL FACTORS 
1.4.1 Alcohol 
Heavy alcohol consumption is linked with teratogenicity.1Another outcome of high 
alcohol consumption during pregnancy is foetal alcohol syndrome. Features of this 
syndrome include prenatal and postnatal growth failure, developmental delay, 
microcephaly, eye changes (including involvement of the epicanthal fold), facial 
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abnormalities and skeletal joint abnormalities.1,6Alcohol use during pregnancy is 
also associated with an increased rate of spontaneous abortions, placental 
abruption and LBW delivery.1 Due to insufficient data to recommend any safe level 
of alcohol consumption during pregnancy, pregnant women are advised to abstain 
from alcohol during pregnancy.1,6 
 
The mechanisms by which alcohol affects the foetus are still unclear. Alcohol may 
accumulate to toxic levels when crossing the placenta, which are damaging during 
blastogenesis and cell differentiations. Foetal damage may also be caused by 
dietary deficiency (i.e. folic acid, magnesium and zinc), which is known to occur 
among heavy drinkers.6 
 
1.4.2 Smoking 
Smoking, whether a woman is pregnant or not, exerts harmful effects. Pregnancy 
just dramatically magnifies the hazards of this practice: smoking during pregnancy 
harms the placenta, the embryo, the foetus and the infant and child in later life.6 
 
Cigarette smoking during pregnancy is associated with greater risk of spontaneous 
abortion, placenta praevia, placental abruption, ectopic pregnancy, preterm birth, 
foetal growth retardation and sudden infant death syndrome.9 The more a pregnant 
woman smokes, the smaller her infant will be.6 On average, infants of mothers 
who smoke weigh 200 g less than those born to non-smoking mothers.6 The deficit 
reflects a disproportionate lack of lean tissue. This LBW reflects a small-for-
gestational-age profile, indicating that maternal smoking directly retards foetal 
growth rate.6 
 
Tobacco smoke contains hundreds of compounds that are harmful, including 
nicotine and carbon monoxide.6 Carbon monoxide and nicotine from smoking 
increase foetal carboxyhaemoglobin9 and restrict the blood supply to the growing 
foetus and so limit oxygen and nutrition delivery and waste removal.6 Carbon 
monoxide in pregnant mothers’ blood may deprive the developing foetus of the 
oxygen necessary for optimal growth.6 
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1.5 THE NEED FOR NUTRITIONAL SUPPLEMENTATION PROGRAMMES 
The Millennium Development Goals (MDGs) are eight goals that all United Nations 
(UN) member states have agreed to try to achieve by the year 2015.60 The UN 
Millennium Declaration, signed in September 2000, committed world leaders to 
combating poverty, hunger, disease, illiteracy, environmental degradation and 
discrimination against women. The MDGs are derived from this declaration and all 
have specific targets and indicators. South Africa, as one of the UN member 
states, has committed to the eight MDGs and included them in a national set of 10 
priorities.61 The eight MDGs are 1) to eradicate extreme poverty and hunger, 2) to 
achieve universal primary education, 3) to promote gender equality and empower 
women, 4) to reduce child mortality, 5) to improve maternal health, 6) to combat 
HIV/AIDS, malaria and other diseases, 7) to ensure environmental sustainability 
and 8) to develop a global partnership for development.61 MDG 5 (to improve 
maternal health) has two targets, namely 1) to reduce by three quarters, between 
1990 and 2015, the maternal mortality ratio and 2) to achieve, by 2015, universal 
access to reproductive health.62 Maternal deaths per 100 000 live births were 870 
for sub-Saharan Africa in 1990. This value declined to 640 deaths per 100 000 live 
births in 2008. Despite this decline, a woman’s risk in sub-Saharan Africa to die 
from preventable or treatable complications of pregnancy and childbirth over the 
course of her life is one in 31, compared to only one in 4 300 in the developed 
regions.63 South Africa’s MDG target for 2015 for maternal mortality is 38 deaths 
per 100 000 live births, far below the actual 625 deaths per 100 000 live births 
found in 2007.61 South Africa will probably not meet the target of 38 maternal 
deaths per 100 000 live births by 2015. The target of 100% antenatal care 
coverage (at least one booking visit and at least four follow up further visits) was 
met by South Africa in 2009 with 102,8%.61 South Africa should continue to look 
for strategies to optimise pregnancy outcomes.  
 
The Centers for Disease Control and Prevention (CDC) has made 10 
recommendations for preconception interventions to optimise pregnancy 
outcomes. These recommendations are 1) individual responsibility across the life 
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span, 2) consumer awareness, 3) preventive visits, 4) interventions for identified 
risks, 5) interconception care, 6) prepregnancy check-up, 7) health insurance 
coverage for women with low incomes, 8) public health programmes and 
strategies, 9) research and 10) monitoring of improvements. Recommendation 2 
(consumer awareness) suggests health promotion campaigns, which include 
healthy diet and optimal weight. One of the 10 action steps that should be taken 
during counselling (Recommendation 3: preventive visits) suggests counselling 
concerning nutrition, folic acid intake and weight management.64 
 
In South Africa there are two kinds of medical health care available: private sector 
and governmental sector. Only the wealthy make use of private sector health care 
while governmental sector health care allows anyone to make use of government 
health care facilities, despite the patient’s gender, ethnic descent or employment 
status.65 The governmental sector thus makes provision for health insurance 
coverage for women with low incomes (Recommendation 7 of the CDC). 
 
Within the governmental health care system, there are primary health care 
facilities, secondary health care facilities and tertiary health care facilities. South 
Africa has nine provinces and each province is divided into districts. Each district 
has primary health care (PHC) clinics to ensure that health care is available to all. 
Already at this level it is mandatory that health care professionals give advice to 
patients on a healthy lifestyle to advocate healthy living and prevent undesirable 
fatal health outcomes66 since South Africa is bound to the Alma-Ata Declaration of 
1978 as well as the Kopanong Declaration on Primary Health Care of 2003. These 
strategies comply with recommendations 1, 2, 3, 4 and 8 of the CDC.  
 
Examples of a few strategies in place to promote a healthy lifestyle and prevent 
fatal outcomes in the South African context are the Baby-Friendly Hospital 
Initiative, prevention of mother-to-child transmission of human immunodeficiency 
virus (HIV), Road to Health Chart (child growth monitoring and promotion), food 
fortification, nutrition education as part of the school curriculum, school feeding 
programmes and the Nutrition Supplementation Programme (NSP).67South Africa 
also has its own Medical Research Council that supports the Department of Health 
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in monitoring and evaluation of the effectiveness of current policies and strategies 
and the health status of South Africans.66 This complies with recommendations 9 
and 10 of the CDC. Although all these strategies are in line with the CDC’s 
recommendations, there may be a problem with the implementation of these 
strategies. South African clinics tend to have a shortage of health care 
professionals, have limited resources and experience financial constraints due to a 
strict budget within which they have to render an effective service to all South 
Africans.67 
 
Pregnant women with a poor nutritional intake can benefit from nutrition 
supplementation, which can be taken in the form of additional energy, protein, 
vitamins or minerals.1 Multivitamin and -mineral supplementation is recommended 
for women with iron deficiency anaemia or poor-quality diets. Multivitamin and -
mineral supplementation may also be beneficial in pregnant women who are 
infected with HIV.9 In HIV-infected women in Tanzania, a supplement containing a 
vitamin B complex, vitamin E and vitamin C slowed progression of the disease, 
reduced some of the complications of HIV and reduced the incidence of LBW 
infants compared to using iron and folic acid alone.68,69 It may be that micronutrient 
supplementation protects the integrity of oral and gastrointestinal epithelia and 
enhances local and systemic immunity and hence reduces the progression of 
HIV.68 Multivitamins may also reduce HIV replication because viral loads were 
significantly lower after supplementation.68 Maternal micronutrient supplementation 
in rural Nepal decreased the incidence of LBW neonates by almost 15%,70 and in 
a randomised, placebo-controlled, doubled-blind trial in Zimbabwe, it was found 
that supplementation might be a feasible strategy to increase birth size.71 
 
1.6 THE INTEGRATED NUTRITION PROGRAMME OF SOUTH AFRICA 
Malnutrition is a serious problem in South Africa.37,72,73Under- and overnutrition 
coexist between and within communities and across age groups. Stunting among 
children aged 1–9 years was found to be 18% in the NFCS-FB-I and underweight 
9,3%.37 In the same age group, 10% of the children were classified as overweight 
according to international standards and 4% as obese. Among women of 
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childbearing age, the prevalence of chronic energy deficiency (defined as a BMI < 
18,5) was 4,6%. On the other end of the scale, the combined prevalence of 
overweight and obese women was 51,5%. When studying the UNICEF conceptual 
framework, one sees that inadequate food intake and illness are the most 
immediate causes of this malnutrition.20 One of the underlying causes, according 
to the conceptual framework, that could influence inadequate food intake is 
household food insecurity. The NFCS-FB-I found that one out of two households 
experienced hunger, one out of four was at risk of hunger and only one out of four 
appeared to be food secure.37 This means that almost half of the South African 
population experiences household food insecurity. Some of the basic factors that 
are outlined by the framework to contribute to the malnutrition are poverty and a 
lack of resources.20 
 
During the elections of 1994 in South Africa, the Department of Health was tasked 
to implement a national feeding scheme. During 1995 the Integrated Nutrition 
Programme (INP) was born.74 Some of the main aims included were reduction of 
the prevalence of LBW neonates, reduction of iron deficiency anaemia in pregnant 
women and reduction of subclinical vitamin A deficiency.74 In September 2002, 
once again one of the strategic objectives of the INP was to decrease the 
prevalence of LBW neonates and underweight in pregnant and lactating women.75 
Today the NSP of the Health Facility-Based Nutrition Programme (HFBNP) is seen 
as part of the broader INP that is implemented at primary health care level. Two 
focus points of the HFBNP are 1) to improve the feeding practices of pregnant and 
lactating women and 2) to ensure that health workers are trained and encouraged 
to implement the policy.76 
 
The South African Government compiled the INP in order to address the 
malnutrition problem by providing adequate health care and nutrition to South 
Africans who are at risk of malnutrition, throughout the lifespan.77 The INP 
supports exclusive breastfeeding of infants younger than six months, growth 
monitoring of children younger than five years, poverty alleviation, food institutions, 
deworming and the primary school nutrition programme.77 The INP makes 
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provision for the NSP, which includes supplements (e.g. vitamin A) and nutrition 
advice for specific conditions (e.g. HIV and tuberculosis).   
 
Statistical information on the number of pregnant women registered with the NSP 
in the Western Cape Province is unavailable.78 Statistical data collection and 
information cluster pregnant and lactating women together, which causes data to 
be reflective of both groups and not pregnant women alone. Available data also 
reflect only new pregnant and lactating women enrolled in the NSP and not those 
women already in the NSP. No data are available on the number of pregnant 
women exiting the NSP successfully. Due to the lack of specific data for pregnant 
women registered with the NSP, it is difficult to draw conclusions regarding 
pregnant women and the NSP.  
 
In future literature the NSP will be known as the Nutrition Therapeutic Programme 
(NTP). The name change occurred during 2011 on request from the South African 
Government. Since the change was implemented after completion of this study, 
the investigator will use the term NSP in this document.   
 
1.6.1 Summary of Nutrition Supplementation Programme for pregnant 
women 
During the first visit to the basic antenatal care (BANC) clinic, pregnant women 
should be evaluated according to the entry criteria (see Table 1.2) for their specific 
target group of the NSP. Identified patients are entered into the NSP and they 
should then visit the counsellor on a monthly basis to be re-evaluated to ensure 
positive progress regarding nutritional status and effectiveness of intervention. 
During each visit the identified pregnant women should receive nutritional 
products, as stipulated in Table 1.2.  
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Table 1.2: Summary of Nutrition Supplementation Programme for pregnant 
women76 
Target group Entry criteria Products available 
Pregnant women • Insufficient growth 
according to 
symphysis-fundus 
graph 
• Mid upper arm 
circumference < 23 cm 
• Enriched porridge 
• Enriched nutritional 
supplementary drink for 
adults 
• B-immune energy drink: 
40 g sachets 
• High-energy enriched 
paste (if no history of 
nut allergy) 
 
Pregnant women are also eligible to receive micronutrients (folate and iron) with 
each visit to the BANC clinic.  
 
1.7 MOTIVATION FOR STUDY 
Nutrition during pregnancy plays an important role in the newborn infant’s weight 
as well as in long-term adverse health outcomes, for example ischaemic heart 
disease, hypertension and NIDDM.1,26Factors such as LBW, disproportion in head 
circumference and below-average length and weight are markers of lack of 
nutrients at particular stages of gestation, which reflect adaptations that the foetus 
made to sustain its development. This adaptation has the potential to permanently 
programme the body’s structure and function.45 To maintain health during 
pregnancy, adequate energy, vitamin and mineral intake is essential.1 Increase in 
daily intake or supplementation can help pregnant women to meet their acquired 
needs, although supplementation with iron and folate is recommended for all 
pregnant women.1  
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Although a high dose vitamin A is contra indicated for pregnant women, it is 
indicated that post partum mothers should receive vitamin A after delivery. 
Pregnant women should therefore be aware of this intervention, and by including 
vitamin A in the study, the data could be used to determine awareness of vitamin A 
among pregnant women. In developing countries, such as South Africa, vitamin A 
deficiency is also a reality.11,12,80 Vitamin A deficiency during pregnancy can lead 
to intrauterine growth retardation.11 
 
Almost 12 years have passed since the initiation of the INP and yet no study has 
been conducted to fully evaluate the implementation and efficacy of the nutritional 
supplementation programmes available to pregnant women. For the INP to be 
successful, it relies on two components found in the health care system: those who 
implement the programme and those who need to follow the instructions. Health 
care workers, such as nursing personnel, would qualify as those who implement 
the programme and patients, such as pregnant women, would qualify as those 
who need to comply with the interventions. To follow the instructions (comply), 
pregnant women must receive adequate information, understand the instructions 
correctly and be motivated to fulfil the intervention. For the INP to be successful, 
not only do pregnant women need to receive adequate information but they also 
need to receive the correct supplements. Not receiving these supplements or 
incorrect usage thereof could lead to health risk for the pregnant woman and her 
unborn infant. As the nutrition supplementation programmes relies largely on the 
compliance of the individual receiving the product(s), it is thus important to 
understand how well it is implemented at clinic level and adhered to at household 
level to ensure patients reap the full benefit it has to offer.  
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2.1 AIM 
To evaluate the implementation of the NSP for pregnant women in the Cape Town 
Metropolitan Area of the Western Cape Province, South Africa. 
 
2.2 OBJECTIVES 
1. To determine pregnant women’s awareness regarding the NSP food-, 
folate-, iron- and vitamin A supplementation programmes at PHC clinics.   
2. To determine whether pregnant women visiting the PHC clinics qualified for 
the NSP food-, folate-, and iron supplementation.   
3. To determine whether qualifying pregnant women visiting the PHC clinics 
received and were compliant with the prescribed NSP food-, folate- and iron 
supplementation regimens.   
 
2.3 METHODOLOGY 
This thesis serves as a substudy that forms part of a larger parent study: 
Evaluation of selected components of health facility-based nutrition programmes in 
the Western Cape Province of South Africa (Ethics approval number N07/10/232, 
Appendix H).   
 
The aim of the parent study was to examine various nutrition supplementation 
programmes offered at PHC clinics and HIV/AIDS clinics in the Western Cape 
Province. Target groups of the parent study included children and their mothers, 
pregnant and lactating women and patients with HIV/AIDS and/or tuberculosis who 
visited these clinics.   
 
As part of the parent study project, the evaluation of the NSP for children under 
five years and their caregivers has already been conducted by two master’s 
students of Oslo University, Norway.81,82A qualitative study has also been done 
among HIV/AIDS patients at the various PHC clinics in the Western Cape Province 
by another master’s student of Oslo University.83 The present substudy focused its 
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research on pregnant women visiting BANC clinics in the Cape Town Metropolitan 
Area.   
 
2.3.1 Study design 
A cross-sectional descriptive study was conducted amongst pregnant women 
visiting all PHC clinics hosting BANC in the Cape Town Metropolitan Area, with the 
exception of one clinic that was used in the pilot study.   
 
2.3.2 Study population 
The study population consisted of all pregnant women visiting public BANC clinics 
in the Cape Town Metropolitan Area on the day the researcher visited the clinic. 
Other health care units that provide BANC include hospitals and maternity 
obstetric units. These units were not targeted by the parent study and were 
excluded during sampling. 
 
The study population was derived from the poorer part of the population, who 
could only afford to visit a government-funded clinic since services at these clinics 
are free of charge. Most of the clinics were situated in the lower sociodemographic 
areas of the Cape Town Metropolitan Area, such as Gugulethu, Khayelitsha, 
Masiphumelele in Noordhoek, Manenberg and Du Noon. These areas are known 
for their informal settlements, poor sanitation and high crime rates.84 
 
2.3.3 Sample selection 
At the time of data collection, in the Cape Town Metropolitan Area only 14 PHC 
clinics hosted BANC. One of the 14 clinics was chosen randomly for validating the 
questionnaire and was not included in sampling.   
 
Census sampling of the remaining BANC clinics were used by including all 13 
clinics that hosted BANC in the Cape Town Metropolitan Area. Nonrandom quota 
sampling was used to select 7–10 pregnant women at each clinic, giving a total 
sample size of 114. On arrival at each clinic, whichever pregnant woman was first 
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in line and met the entry criteria was ask to participate in the study. After 
completing the interview with a pregnant woman, the next pregnant woman in line 
was asked to participate. The interviewer continued this process until the quota of 
pregnant woman was met. Only women that met the stated selection criteria were 
included in the study.   
 
2.3.3.1 Inclusion criteria 
Participants were included in the study if they complied with the following inclusion 
criteria:  
• Had to be pregnant.   
• Had to attend the selected BANC clinic on the day of data collection.   
• Had to be 18 years or older.   
• Informed consent had to be given. 
• Had to be able to communicate in Afrikaans, English or Xhosa.   
 
2.3.3.2 Exclusion criteria 
Participants were excluded from the study if they complied with the following 
exclusion criteria: 
• Not pregnant. 
• Younger than 18 years old. 
• Did not give written informed consent. 
• Participated in the pilot study. 
 
2.4 DATA COLLECTION 
Data collection took place from May 2008 to June 2008. Due to time constraints, 
only one day was spent at each clinic where 7–10 participants were interviewed by 
the investigator on weekdays from 07:30 till 16:00. Before each interview, the 
investigator explained the study objectives to the participant and it was stated 
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clearly that participation was voluntarily. If participants agreed to participate, the 
consent form was explained to them and they were kindly asked to sign the 
consent form. Interviewing only started after each participant had signed the 
consent form.   
 
The investigator, who can speak Afrikaans and English fluently, collected the data. 
For those participants who could only speak Xhosa, the investigator made use of a 
hired interpreter. The interpreter was familiar with translation work since she 
translated for health care professionals in the community on a regular basis. 
Before the study commenced, the interpreter was informed about the objectives of 
the study and the questionnaire was explained to her in detail.   
 
A week before commencing data collection, each clinic was phoned and informed 
about the study and letters of approval from the ethics committees of Stellenbosch 
University and the Department of Health were faxed to the clinics where possible 
(see Appendix A). If not possible, an address was obtained from the particular 
clinic to post certified copies of documentation. Clinics were notified telephonically 
regarding the date and time of planned visits. A day prior to data collection, the 
clinic was phoned again to confirm the date and time of arrival.   
 
2.4.1 Questionnaire 
A structured questionnaire for the pregnant women was completed during the 
interviews with individual participants. It was adapted from the questionnaire 
developed for the parent study and consisted of 55 questions divided into two 
sections: sociodemographic data (18 questions) and supplementation data (37 
questions). The supplementation section was divided into four subsections: 
introduction (six questions), vitamin A supplementation (10 questions), nutrition 
supplementation (12 questions) and micronutrient supplementation (nine 
questions). Each of the subsections was completed by the investigator according 
to the participants’ responses. These questions were developed in collaboration 
with dieticians from the Provincial Department of Health, Western Cape. The 
questionnaire was available in Afrikaans, English and Xhosa (see appendixes B, C 
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and D) with translations by professional translators from the Language Service of 
Stellenbosch University.   
In each subsection (vitamin A, nutrition and micronutrient supplementation), the 
questions were aimed towards determining the awareness of the participants of 
the supplementation programme during pregnancy and whether these participants 
received the supplements and complied with the intervention.  
 
2.4.1.1 Questions to assess awareness of the supplementation programmes 
among participants 
The following questions aimed to assess the awareness of the participants of the 
supplementation programmes: 
• Have you heard about any of these nutritional supplementation offered at 
this clinic? (Question 20) 
• Have you seen any of these supplements? (Show examples of 
supplements) (Question 21) 
Within each subsection (vitamin A, nutritional and micronutrient supplementation),  
questions were asked to determine awareness for the specific subsection (i.e. 
vitamin A supplementation): 
• Has anyone talked to you about vitamin A supplementation? (Question 29) 
• Have you received any written information about vitamin A 
supplementation? (Question 32) 
 
2.4.1.2 Questions to determine whether qualifying pregnant women received 
and are compliant with the prescribed supplementation regimens 
The following questions aimed to assess whether the qualifying pregnant women 
received prescribed supplements and whether they were compliant with the 
intervention: 
• Have you received any of these supplements for yourself? (Question 22) 
• If yes, what type of supplementation have you received? (Question 23) 
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The questions within each subsection to determine whether qualifying pregnant 
women received supplementation and whether they complied with the intervention 
were as follows (i.e. micronutrient supplementation): 
• Do you remember when you received the micronutrient supplementation? 
(Question 48) 
• Who gave it to you? (Question 49) 
• Have you experienced any problems taking the micronutrient 
supplementation? (Question 54) 
• Have you experienced any side effects with the micronutrient 
supplementation? (Question 55) 
 
2.4.1.3 Pilot study 
A pilot study was conducted before the substudy commenced in order to improve 
face validity. A BANC clinic was chosen randomly from the 14 BANC clinics 
available in the Cape Town Metropolitan Area. At this clinic, 10 pregnant women 
were asked to participate in the pilot study. This BANC clinic and participating 
pregnant women did not form part of the study population for the actual study.   
 
2.4.1.4 Changes to questionnaire 
Following the pilot study of the 10 pregnant women visiting the BANC clinic, 
adaptations were made to the questionnaire in order to improve face validity. 
Adaptations to questions included the following: In the anthropometric section, 
questions were aimed at gathering information regarding pregnancy 
anthropometry (for example, gestational period, symphysis-fundus [SF] 
measurement and mid upper arm circumference [MUAC] were included). In the 
case of Question 19 (breastfeeding practices), questions were put in a futuristic 
form, for example, “Do you plan to breastfeed your baby?” instead of “Did you 
breastfeed your baby?” In the micronutrient section, Question 50 (“Did you take 
the micronutrients at the clinic?”)was left out since the pregnant women were 
supposed to receive supplementation to take at home and not at the clinic.   
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2.4.2. Determining whether participants qualified for the supplementation 
programme 
The participant’s age, weeks of gestation and SF measurement were recorded 
from the participant’s medical file. The SF measurement could be read from a 
graph that was available in the participant’s file. The graph had different intervals 
for gestation in weeks (on the X-axes) and SF measurement in centimetres (on the 
Y-axes). Across the graph there were three different percentile curves, namely the 
10th, 50th and 90th percentiles. Insufficient growth was defined as a measurement 
below the 10th percentile or a measurement that showed growth stagnation/decline 
(even if the measurement was above the 10th percentile).85 Insufficient growth was 
seen as inclusion criterion for the NSP. These measurements were taken by the 
nursing staff at the clinic.   
 
The MUAC, in centimetres, was measured by the investigator using a measuring 
tape to determine eligibility for the NSP food supplementation. An MUAC below 23 
cm was used as entry criterion, as stipulated in the Department of Health’s policy 
and implementation guidelines for the NSP of the HFBNP.76 The procedure 
followed for the anthropometric measurement was as follows86: 
For the midpoint of the upper arm: 
• The measuring apparatus was checked by making sure that the 
material of the measuring tape was nonelastic, that measure 
indicators were in millimetre and/or centimetre and that those 
indicators were clearly marked.   
• The measurement was taken on the right arm.   
• The woman was standing in an upright position with her feet 
together.   
• The arm was bent at 900 at the elbow.   
• The palm of the hand showed upwards.   
• The midpoint between the upper edge of the acromion and the 
point of the olecranon was taken, in the posterior position.   
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MUAC: 
• The measurement was taken on the right arm.   
• The measurement was taken on the horizontal plane on the same 
level as the midpoint of the arm.   
• The woman stood with her arm hanging relaxed beside her hip.   
• Soft tissue was not pressed together.   
• The measurement was taken to the last millimetre.   
• The mean of three measurements was used as the MUAC.   
 
2.5 ETHICS 
2.5.1 Informed consent 
The consent forms (see appendixes E, F and G) were thoroughly explained to the 
participants before data collection. Names of the clinics and participants were only 
used on the consent forms, and each participant received a copy of the form. 
Participants had a choice in language preference of Afrikaans, English or Xhosa. It 
was clearly stated before the interview that participation was voluntary. The 
participants had the option to withdraw from the study during any stage of the 
interviewing process.   
 
2.5.2 Confidentiality 
Each participant had an identification number, which was randomly allocated and 
entered on the questionnaire form in the allocated space. The identification 
number consisted of an acronym associated with the clinic visited and a number 
between zero and 10. The number was allocated as participants entered the room 
for the interviewing process. No names or personal details that could be linked to 
participants were obtained. All collected data were thus anonymous.  
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2.5.3 Ethics approval 
The study was approved by the Ethics Committee of the Faculty of Health 
Sciences, Stellenbosch University (see Appendix H, ref. no. N07/10/232) and the 
Provincial Department of Health. 
 
2.6 STATISTICAL ANALYSIS 
Data was captured electronically with Microsoft Excel® from the questionnaires 
and regularly cross-referenced to ensure precision of data transfer. The researcher 
made use of a statistician who used the Microsoft Excel® package for statistical 
analysis of data, including calculations of the minimum, maximum, average and 
standard deviation of base parameters. Microsoft Excel® was used for 
configuration of graphs and figures. Descriptive statistics were used. 
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3.1 DESCRIPTION OF THE STUDY POPULATION 
3.1.1 Participants 
A total of 114 pregnant women were sampled from 13 BANC clinics in the Cape 
Town Metropolitan Area and were interviewed during the study. The number of 
women who participated from each clinic varied from seven to 10, with four clinics 
having 10 participants, five clinics having nine participants, two clinics having eight 
participants and two clinics having seven participants. One of the clinics’ having 
only seven participants was due to poor attendance, and at the other clinic this 
was due to xenophobia attacks that took place during data collection.  
 
3.1.2 Areas and population groups 
The clinics were situated in the lower sociodemographic areas of the Cape Town 
Metropolitan Area, such as Gugulethu, Khayelitsha, Masiphumelele in Noordhoek, 
Manenberg and Du Noon.   
 
The largest population group represented was the black population, followed by 
the coloured population. Less than 2% was represented by the white population, 
and no Indian women were interviewed (see Table 3.1).   
 
Table 3.1: Representation of the population groups   
Population group n % 
Black 72 63.2 
Coloured 40 35 
White 2 1.8 
Indian 0 0 
Total (n) 114 100 
 
Representation of the different population groups varied from 1:7 (black:coloured) 
to 7:1 (black:coloured); thus, a clinic was either black dominant or coloured 
dominant. The most heterogeneous clinic had a ratio of 3:4 (black:coloured).  
There was very poor representation from the white population.   
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3.1.3 Socioeconomic and demographic factors 
Participants had a mean age of 26 years (±5,5 SD).When looking at the total 
number of participants, one sees that 42% (n = 48) of participants did not have any 
other children to look after. Thirty-three per cent (n = 38) had one other child to 
look after, 18% (n = 20) had two other children to look after and 7% (n = 8) had 
three to four other children to look after. There were no pregnant women with five 
or more children to look after at home (see Table 3.2).   
 
Table 3.2: Sociodemographic factors of participants   
Characteristics Black 
(n = 72 ) 
Coloured 
   (n = 40 ) 
White 
  (n = 2 ) 
Total 
(n = 114 ) 
 Median Median Median Median Min Max 
Age (y) 25,71 27,13 25,00 26,27 18 49 
Number of children 1 1 0 1 0 4 
Persons living in 
house 
2 3 1 3 1 14 
Household income 
(rand/month) 1 001–3 000 1001–3 000 1 001–3 000 1 001–3 000 0 > R5 000 
Education (grade) 11–12 8–10 8–10 11–12 Primary Tertiary 
Money spent on 
food (rand/month) 101–200 201–400 101–200 201–400 0–100 > 400 
 
The lowest percentage of participants had a primary school and tertiary level 
education (both 10%), followed by Grade 8–10 (40%). The highest percentage of 
participants had an education level of Grade 11–12 (41%). 
 
Forty-two per cent of participants (n = 48) had an income of R1 001 to R3 000 per 
month per household. Participants with no income for the household was 5% (n = 
6), and 13% (n = 15) had an income of more than R5 000 per month (see Figure 
3.1).   
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 Figure 3.1: Total household income per month for the total group 
 
The amounts of money spent on food per month by the majority of the participants 
were between R201 and R400 (
R0 and R100 per month on food, and 15% (n = 17) spent more than R401 per 
month on food. Of the black population,
monthly income on food, while 5
between R201 and R400 per month (see Table 3.3).  
 
Table 3.3: Income spent on food per month
 Black
Number of 
R0–R100 14 (19
R101–R200 28 (39
R201–R400 22 (31
> R401  8 (11)
Total 72 
 
When asked about the work status of the pregnant women, 55% (n = 62) 
they were stay-at-home mothers/women. Pregnant women that earned a wage 
R 1001 -
R 3000
(42%) (n=48)
R 3001 -
R 5000
(16%) (n=18)
> R 5000
(13%) (n=15) 
34 
 
39%). Thirteen per cent (n = 15) spent between 
 39% (n = 28) spent R101– R200 of their 
4% (n = 22) of the coloured population spent 
 
 
 Coloured White Total 
participants (%) 
) 1 (3) 0 15 (13) 
) 8 (20) 1 (50) 37 (33) 
) 22 (54) 1 (50) 45 (39) 
 9 (23) 0 17 (15) 
40 2 114 
R 0
(5%) (n=6) R 1 - R 500
(9%) (n=10)
R 501 - R 1000
(15%) (n=17)
 
(n=114) 
said that 
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were 34% (n = 39), and only 8% (n = 9) were self-employed. Although being a 
student was not classified as ‘work’, 3% (n = 3) gave it as an ‘other’ option. 
 
Comparing the work status of the participants with their education level, one sees 
that 47% (n = 29) of the participants who stayed at home had an education level of 
Grade 8–10 and 5% (n = 3) had a tertiary education. Of those earning a wage, 
41% (n = 16) had an education level up to Grade 8–10, 41% (n = 16) had an 
education level up to Grade 11–12 and 13% (n = 5) had a tertiary qualification.   
 
Most pregnant women were married (42%), followed by 37% who were living alone 
and 18% who lived with their partner but were not married. Only 3% were divorced 
and there were no widows.   
 
More of the black population, 46% (n = 33) compared to the 22% (n = 9) of the 
coloured population, lived alone (see Table 3.4). In the coloured population 50% (n 
= 20) and in the black population 37% (n = 27) were married. Fourteen per cent (n 
= 10) of the black population lived with their partner but were not married. In the 
coloured population, 22% (n = 9) lived with their partner, not being married. In 
total, 18% (n = 20) of respondents lived with their partner (not married), 37% (n = 
42) lived alone and 41% (n = 48) were married.   
 
Table 3.4: Marital status of the pregnant women for different population 
groups   
 Black Coloured White Total 
Number of participants (%) 
Divorced 2 (3) 2 (6) 0 4 (4) 
Live alone 33 (46) 9 (22) 0 42 (37) 
Live with partner (not married) 10 (14) 9 (22) 1 (50) 20 (18) 
Married 27 (37) 20 (50) 1 (50) 48 (41) 
Total 72 40 2 114 
 
The majority of the participants lived in a brick house (54%), followed by a total of 
46% who lived in a ‘shack’ (informal settlement known to the lower socioeconomic 
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classes in South Africa). Of these shacks, 40% were made of tin and 60% were 
made of wood. 
 
For their water source, 74% of participants had their own tap and 26% made use 
of a communal tab to collect water. No one reported using a river or borehole to 
collect water from. Regarding toilet facilities, 85% had a flush toilet to use, 11% 
made use of the bucket system and only one (1%) reported using a pit latrine.   
 
In summary, most of the participants (41%) had an education level of Grade 11–
12. Forty-two per cent had an income of between R1 001 and R3 000, of which 
between R201 and R400 (39%) was spent on food per month. The majority of 
participants stayed at home with their children (54%), while 42% earned a wage or 
was self-employed. Pregnant women were more likely to be married (41%), with 
37% who lived alone. They tended to stay in a brick house (54%), with 74% 
reporting having their own tap to obtain water from. Eighty-five per cent reported 
that they made use of a flush toilet.   
 
3.1.4 Reasons for clinic attendance 
Reasons given by pregnant women for attending the clinic on the particular day 
are shown in Figure 3.2. Reasons classified under ‘other’ included assisting a 
friend to the clinic and requesting a letter for work stating pregnancy status from 
the clinic. The average pregnant women visited the clinic for the first time during 
the 18th week of gestation (mid second term of pregnancy).   
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 Figure 3.2: Reasons for attending the clinic (n = 114)  
3.1.5 HIV status 
Participants were asked whether they had any chronic diseases, and 14% (n = 16) 
indicated that they were HIV positive.  
 
3.1.6 Breastfeeding 
Most of the pregnant women (
breastfeed their babies. Of those who did not plan to breastfeed (22%; n = 25), 
52% (n = 13) gave HIV infection as a reason, 16% (n = 4) said that due to work 
responsibilities they could not breastfeed, 8% (n = 2) thought
8% (n = 2) still had to decide whether they were going to breastfeed, one person 
(4%) thought it would spoil her figure, one person (4%) thought that baby milk 
formulas/products were better than breast milk, one person (4%) said that 
husband would not allow it and one person (4%) said that she would be staying in 
Cape Town while her baby was going to her mother’s in the Eastern Cape and 
distance was thus a problem.  
 
Pregnant women who indicated that they planned to breastfeed wer
how long they planned to do so, and 10% (n = 9) said for three months, 21% (n = 
19) planned to breastfeed for 4
Total, disease, 2
Total, first visit, 
39
37 
 
 
 
78%; n = 90) indicated that they planned to 
 it would be painful, 
 
–6 months, 26% (n = 23) planned to breastfeed for 
Total, follow-
up, 65
Total, other, 8
 
her 
e asked for 
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7–12 months, 35% (n = 31) planned to breastfeed for 13–24 months and 8% (n = 
7) planned to breastfeed for more than 24 months.   
 
In summary, although most of the pregnant women indicated that they planned to 
breastfeed, 10% (n = 9) indicated that they did not plan to breastfeed for longer 
than three months. For those who did not plan to breastfeed, the majority (52%; n 
= 13) gave HIV infection as a reason.   
 
3.1.7 Opinions of participants who did not receive nutritional 
supplementation 
For the participants who did not receive any nutritional supplementation (food 
supplement and micronutrients), the question was asked whether they had any 
opinion on why they did not receive the supplementation. Eighteen per cent (n = 8) 
had no opinion on not receiving supplementation, 70% (n = 31) was of the opinion 
that it was because it was their first visit to the BANC clinic, 5% (n = 2) was of the 
opinion that it was related to their HIV status, 5% (n = 2) thought it was because 
they had seen a private doctor and 2% (n = 1) had blood taken that indicated that 
she did not need supplementation. 
 
3.2 PARTICIPANTS’ AWARENESS REGARDING THE NUTRITIONAL 
SUPPLEMENTATION PROGRAMMES FOR PREGNANT WOMEN 
3.2.1 Vitamin A supplementation programme 
From the 114 participants, 13% (n = 15) indicated that they had heard about 
vitamin A in the past, and 5% (n = 6) indicated that they had seen the vitamin A 
capsules and/or drops. No one reported having used these capsules/drops before. 
 
3.2.2 NSP food supplement 
Twenty-five per cent (n = 29) of the participants had heard about the NSP food 
supplements while 24% (n = 27) had also seen these. The one participant who 
received the supplementation had talked to an NSP counsellor and had found it 
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helpful. Advice given concerning food habits was for the pregnant woman to 
increase vegetable (potato, carrots and cabbage) intake. This woman had not 
received any written information. She was of the opinion that she received the 
supplementation ‘to make her strong’.  
 
3.2.3 Micronutrient supplementation programme: folate and iron 
Forty-seven per cent (n = 53) of the participants had heard about the supplements 
that pregnant women should receive from the clinic. By being showed the different 
packages in which the supplements were given as well as the actual appearance 
of the supplements, 79 participants recognised them.  
 
Forty-six per cent (n = 32) of participants could remember that someone had 
talked to them about micronutrient supplementation. A professional nurse had 
talked to 88% (n = 28) of the women, a doctor to 9% (n = 3) and a professional 
nurse and a doctor to 3% (n = 1). Eighty-one per cent (n = 26) had found the 
verbal information helpful, 6% (n = 2) had found it confusing and 13% (n = 4) said 
that they had not found it helpful at all. Only three (4%) of the participants indicated 
that they had received written information about supplements during pregnancy. 
All three women said that they had found the written information to be helpful.   
 
Most of the participants (54%; n = 61) had received information (either verbal or 
written) regarding the micronutrient supplements from a professional nurse. Eight 
per cent (n = 9) indicated that a doctor had given them information.  
 
Of the 70 participants who received the micronutrients, 43% (n = 30) did not know 
why they received the micronutrient supplements and 57% (n = 40) indicated that 
they did know why they had to take the supplements. Their opinions on why they 
thought they had to take the micronutrients were as follows: 65% (n = 26) said that 
it was necessary to build/protect/help the baby, 5% (n = 2) said that it was 
necessary for the development of the baby, 3% (n = 1) said that it was because 
she was pregnant, 3% (n = 1) said that it was to improve her appetite, 3% (n = 1) 
said that it was to take dizziness away, 20% (n = 8) said that it was necessary 
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because their iron levels were low and 3% (n = 1) said that the iron helped with the 
development of the baby’s spine.   
 
In summary, a total of one out of five women was aware of the vitamin A 
programme, half of the participants knew about the NSP-food supplementation 
and more than two thirds were aware of the micronutrient supplementation (folate 
and iron).  
 
3.3 NUMBER OF PARTICIPANTS QUALIFYING FOR THE NUTRITIONAL 
SUPPLEMENTATION PROGRAMMES 
3.3.1 Vitamin A supplementation programme 
None of the participants qualified for the vitamin A supplementation, since the INP 
of the HFBNP only provides vitamin A supplementation to children less than five 
years of age and postpartum women 6–8 weeks after delivery.76 
 
3.3.2 NSP food supplement 
The criteria participants had to comply with to be entered into the NSP were as 
follows76: 
• Had to be pregnant.  
• The SF measurement should show insufficient growth of the foetus 
according to the SF graph.  
• The participant had to have an MUAC < 23 cm.  
 
Only 5% (n = 6) had an MUAC < 23 cm and thus qualified to be entered into the 
NSP. The average MUAC was 29,56 cm. Sixty-eight per cent (n = 78) were within 
the interval of 24.73–34.40 cm. The average MUAC was 30,17 cm for black 
participants and 28,56 cm for coloured women.  
 
None of the participants qualified for the NSP due to an insufficient SF 
measurement. Forty-four per cent (n = 50) of the participants had an SF 
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measurement taken that was above the entry level for inclusion in the NSP. Of the 
114 participants, 56% (n = 64) did not have an SF measurement available, of 
which 34% (n = 39) were first visits.   
 
3.3.3 Micronutrient supplementation programme: folate and iron 
Participants had to be pregnant to qualify for the micronutrient supplementation. 
Since all of the participants were pregnant, they were all eligible to receive the 
micronutrients folate and iron. The average weeks of gestation were 24 for the 
total population investigated. Most participants (21%; n = 24) were between 17 
and 20 weeks of gestation. A total of 44% (n = 50) of the participants were before 
20 weeks of gestation. Only 11% of the participants were before 12 weeks of 
gestation. Data for the participants who indicated that the day of investigation was 
their first visit to the BANC clinic showed that 23% (n = 9) were before 12 weeks of 
gestation, 49% (n = 19) were between 12 and 20 weeks of gestation and 28% (n = 
11) were after 20 weeks of gestation. A total of 72% (n = 28) visited the clinic 
before 20 weeks of gestation for the first time.  
 
In summary, only six participants (5%) qualified to be entered into the NSP due to 
an MUAC < 23 cm. Since all of the participants were pregnant, all 114 qualified to 
receive the micronutrients folate and iron.  
 
3.4 NUMBER OF QUALIFYING PARTICIPANTS WHO RECEIVED AND ARE 
COMPLIANT WITH THE PRESCRIBED SUPPLEMENTATION REGIMENS 
3.4.1 NSP food supplement 
Only one out of the six participants who qualified (17%) received the food 
nutritional supplementation. She received the supplementation from a professional 
nurse and she took the products as she was instructed to do. She did not 
experience any problems or side effects with the nutritional products. She shared 
the products with her children at home but never sold the nutritional products. The 
other five participants who qualified but did not receive nutrition supplementation 
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were brought to the attention of the BANC sister so that they could be referred to 
the nutrition counsellor.   
 
3.4.2 Micronutrient supplementation programme: folate and iron 
Sixty-one per cent (n = 70) of the participants indicated that they were using the 
micronutrient supplements. Eighty-seven per cent (n = 61) received the 
micronutrient supplementation from a professional nurse at the clinic, and 13% (n 
= 9) received the supplementation from the doctor.   
 
The average expecting mother first received the micronutrient supplements during 
the 16th week of gestation. Nine per cent (n = 6) said that they experienced 
problems in taking the supplements. Reasons given were that it was difficult to 
swallow (n = 2), the supplements had a bad smell/taste (n = 3) and the 
supplements were not available during the clinic visit (n = 1).   
 
Twenty-six per cent (n = 18) experienced side effects with the micronutrient 
supplementation. The most prominent side effects included nausea (n = 9) and 
constipation (n = 5), while diarrhoea, heartburn and dizziness were also given as 
reasons. 
 
In summary, only a sixth of participants who qualified for the NSP received the 
food supplementation, and almost two thirds of participants received the 
micronutrient supplementation (folate and iron). 
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The main aim of this study was to evaluate the implementation of the NSP for 
pregnant women in the Cape Town Metropolitan Area of the Western Cape, South 
Africa, in 2008. Data were collected to determine participants’ awareness 
regarding the NSP food-, folate-, iron- and vitamin A supplementation 
programmes, to determine whether participants qualified for the NSP food-, folate- 
and iron supplementation, to determine whether participants received the NSP 
food-, folate- and iron supplementation and to determine whether participants were 
compliant with the supplementation programmes.  
 
4.1 SOCIODEMOGRAPHIC AND GESTATION DATA 
The study population consisted mostly of black people and had a mean age of 26 
years. Interesting to note is that most participants indicated that they only had one 
child to look after, with two other persons living in the same house. This could 
partly be explained by the common practice among the black community to send 
their children to the grandmother, living in the rural areas of the country. The child 
then becomes the responsibility of the grandmother to look after. The majority of 
the participants had an education level of Grade 11–12, which explains the 
average income per household per month of between R1 001 and R3 000, of 
which R201–R400 was spent on food. The majority of the participants lived in brick 
houses, with their own tap as a water source and a flush toilet. This is probably 
because participants stayed in the urban areas where water sources such as 
rivers and boreholes are not easy accessible.  
 
Seventy-seven per cent of the participants who visited the clinic for the first time 
had a gestational age of more than 12 weeks. This could be problematic in the 
prevention of NTDs. The rosral end of the neural tube closes on the 23rd day and 
the caudal neuropone closes by the 27th day of development. Ideally, folic acid 
supplementation should start before conception and be continued until at least the 
12th week of gestation.1,15 
 
There may be many reasons for the late first visit to the clinic. Poor sexual 
information and guidance can lead to women not realising that they are pregnant 
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and need to visit the clinic. Some pregnant women may not realise the health 
benefits and better pregnancy outcomes if they attend clinics as soon as they 
realise that they are pregnant. Another reason why pregnant women only visited 
the BANC clinic after 12 weeks of gestation may be that they were afraid to tell 
their employers of their pregnancy status in fear of losing their jobs. It is also 
possible that many of these women did not plan to become pregnant and therefore 
did not visit the clinic before pregnancy to collect information on the importance of 
antenatal care.   
 
The South African Department of Health aim that pregnant women attend 
antenatal care four times during their pregnancy, starting before 20 weeks 
gestation.85 In the light of the latter, the BANC clinics involved in the present study 
are well on track with 72% of the participants first visits being before 20 weeks of 
gestation.  
 
4.2 AWARENESS RELATING TO THE NUTRITIONAL SUPPLEMENTATION 
PROGRAMMES 
4.2.1 Vitamin A supplementation programme 
None of the participants had used vitamin A supplementation before, but 18% (n = 
21) indicated that they were aware of the vitamin A supplementation. It is 
interesting to note that in a previous study conducted in Cape Town, it was found 
that 15% of the eligible mothers received vitamin A supplementation after giving 
birth.44 This correlates quite well with the 18% of pregnant women in the current 
study who indicated that they were aware of vitamin A supplementation. It appears 
that the women were aware of the vitamin A supplementation if they had 
experienced it themselves by receiving it either for themselves or for their infant. 
However, 58% of the participants indicated that they had more than one child to 
look after. If one assumes that these children were their own, one should expect 
the awareness of vitamin A to be closer to 58% and not only 18%. How and where 
the women became aware of vitamin A supplementation is unknown, since the 
questionnaire was only developed to question participants who had received 
vitamin A before. The questionnaire also did not enquire about gravidity; therefore, 
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no statistical conclusion could be reached regarding the effectiveness of the 
implementation of this intervention. It only makes sense that primigravida women 
would not have used vitamin A before.  
 
4.2.2 NSP food supplement 
Almost half of the participants (49%; n = 56) knew about the NSP-food 
supplementation that was available. Once again, their sources of information are 
unknown since the questionnaire did not provide the opportunity to question 
pregnant women regarding their source of information. Only participants who had 
used the products before and/or were currently registered to use this 
supplementation were further questioned. The one participant who was registered 
with the NSP had heard about the food supplements from a professional nurse 
who had referred her to an NSP counsellor. The participants could be unaware of 
the NSP- food supplementation due to a lack of nutrition education / health 
promotion: there may be no pamphlet available to inform pregnant women of the 
NSP, clinic staff and nursing personnel may not educate pregnant women and 
friends may not share that they receive these products from the clinic because 
they are ashamed of being indigent.   
 
4.2.3 Micronutrient supplementation programme: folate and iron 
Seventy-three per cent (n = 83) of the participants were aware of the 
micronutrients folate and iron that pregnant women should receive from the clinic. 
When the participants were asked whether they had ever heard of the 
micronutrient supplementation, only 54 participants could answer positively. After 
being shown the packages and the supplements, 113 of the participants indicated 
that they were aware of the supplements folate and iron that should be issued. 
Visual examples of the supplements assisted in the identification and thus 
increased the awareness of the micronutrients by 25%. This makes sense in the 
light of the education level of the study population. Only 9% indicated that they had 
a tertiary level of education. Most of the participants (41%) only completed Grade 
11–12.   
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Forty per cent had no idea why they should take the micronutrient 
supplementation. This is almost half of the pregnant women who take these 
micronutrients. Of those indicating that they did know the reason for taking the 
micronutrients, only one said that “it helps with the baby’s spine”. Some of the 
participants indicated that it helped the baby (“build/help the baby”), but they could 
not identify in which way it would help the baby. This is despite the fact that about 
40% of the participants could remember that someone did talk to them about the 
micronutrients that they should take. Mostly it was a professional nurse (88%) who 
informed them about the micronutrients.  
 
It could be that the nursing personnel did not educate the pregnant women due to 
a lack of time. It could also be that the information from the professional nurse 
regarding the functions and importance of the micronutrients (folate and iron) was 
insufficient. On the other hand, it may be that the pregnant women were just not 
interested in the information and therefore did not remember/recall what the 
professional nurse had told them. Of the 40% of participants who had received 
information, most had found it helpful. Even the small percentage (4%; n = 4) that 
had received written information felt that it had helped them.  
 
4.3 MEETING THE ENTRY CRITERIA FOR THE NUTRITIONAL 
SUPPLEMENTATION PROGRAMMES 
4.3.1 NSP food supplement 
Most of the participants (68%; n = 77) had an MUAC above the entry criterion of 
23 cm. A small number of participants (5%; n = 6) had an MUAC of < 23 cm. A 
previous study conducted in Cape Town had found that 8% of the mothers with 
children of less than five years old were underweight.19 This occurred four times 
more among mothers in rural areas than in mothers in urban areas. This could 
explain why only six of the participants in the present study had an MUAC < 23 
cm, because this study was undertaken in the urban areas of Cape Town.  
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More than half of the participants (56%; n = 64) did not have an SF measurement 
available. This could partly be explained by the observation that for more than a 
third of these women, it was their first visit to the BANC clinic. Such a 
measurement had then not been taken yet. The remaining participants did not 
have an SF measurement for reasons one can only speculate on. It could be that 
the clinics were understaffed and that there was a lack of appropriate resources, 
some of the obstacles that are known to South African clinics.67 
 
4.3.2 Micronutrient supplementation programme: folate and iron 
All of the participants met the criteria for receiving the micronutrients folate and 
iron, as it is compulsory that they receive it routinely during pregnancy. 
 
4.4 ISSUING AND COMPLIANCE OF PARTICIPANTS WITH PRESCRIBED 
SUPPLEMENTATION REGIMENS 
4.4.1 NSP food supplement 
Although 5% (n = 6) of the participants qualified to be registered with the NSP, 
only one participant (17%) was registered with the programme. After assessment 
according to the questionnaire, it was clear that she was compliant with the NSP. 
The other five participants were brought to the attention of the professional nurse 
working at the BANC clinic. They were also referred to the nutrition counsellor for 
nutrition advice and receiving the NSP- food supplementation. It could be that the 
other five participants had not been referred to the NSP because the nursing 
personnel had not taken their MUAC to screen them as possible participants in the 
programme. Nursing personnel may also be unaware of the entry criteria for 
pregnant women into the NSP and therefore neglect to screen their pregnant 
patients. Nursing personnel should complete a BANC activity checklist for each 
pregnant woman that they see.85On this checklist, maternal weight and height 
should be noted but not MUAC. In the manual that is used by clinics, community 
health centres and district hospitals on guidelines for maternity care85, no 
recommendations are made regarding actions to take when an undernourished 
pregnant patient is identified. This could also have caused participants not being 
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referred to an adequate resource such as a dietician or nutrition counsellor. 
Understaffing of clinics is a known problem,67 which can also lead to nursing 
personnel having a high work load and insufficient time to take the relevant 
measurements.  
 
4.4.2 Micronutrient supplementation programme: folate and iron 
For 75 of the participants, the visit on the day of data collection was not their first 
visit to the BANC clinic for their current pregnancy. Out of these 75 pregnant 
women, 70 (93%) indicated that they did receive the micronutrient 
supplementation (folate and iron). This could support the decrease in LBW 
deliveries from 19,8% to 15,7% in the Western Cape Province47,49 since iron 
supplementation could lead to a decrease in the incidence of LBW deliveries.42 In 
the long run this could lead to fewer South Africans suffering from high blood 
pressure because an indirect correlation between birth weight and hypertension 
was found.58 
 
Six (9%) of the participants experienced problems taking the micronutrient 
supplements, which included difficulty to swallow and bad taste/smell of the 
supplements. Eighteen (26%) of the participants experienced side effects when 
taking the micronutrient supplements, but the side effects were commonly 
associated with pregnancy, for example nausea, constipation and heartburn. It 
could be that the side effects of the supplements were rather ‘symptoms’ 
associated with pregnancy.  
 
It is doubtful that these complaints regarding side effects could contribute to 
suboptimal compliance since it has been reported that side effects are a less 
significant reason for not taking supplements.87 A study done among pregnant 
women in Senegal found that only 13% of women had stopped taking their iron 
and folate supplement due to side effects.88 A review of the literature on 
compliance with iron supplementation found that unavailability of iron supplements 
was the most common reason why women did not take iron supplements.89 In the 
Senegal study, compliance was increased by the role that the midwife played: 15% 
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said that they continued to take the supplementation because the midwife had 
instructed them to do so, and 11% continued with supplementation because the 
midwife had indicated that it would improve their health. Educating women about 
the common side effects associated with iron and folate supplementation and 
helping them to learn to manage these side effects were also found to be effective 
in increasing adherence.89,90The role of the professional nurse at the clinic should 
not be underestimated. Not only can she be a source of information but she can 
also be a motivator to pregnant women to continue taking their iron and folate 
supplementation. Another proposed way of increasing compliance is to provide 
reminders such as posters and calendars about taking supplements.89 
 
 
Stellenbosch University http://scholar.sun.ac.za
 CHAPTER 5: CONCLUSIONS AND RECOMMENDATIONS 
 
Stellenbosch University http://scholar.sun.ac.za
52 
 
 
5.1 CONCLUSIONS 
Eighteen per cent (n = 21) of participants were aware of vitamin A 
supplementation. Although the ideal is for every pregnant women visiting the 
BANC clinic to be aware of the NSP, only half of the participants (49%; n = 56) 
indicated that they knew about the NSP- food supplementation that was available. 
Awareness of the micronutrients folate and iron was very good amongst all of the 
participants indicating that they knew about these nutrients that needed to be 
issued at the clinic.   
 
Five per cent (n = 6) of the pregnant women qualified for the NSP, which in terms 
of underweight among the pregnant women in the Cape Town Metropolitan Area 
does not show such a dark picture. It is, however, a concern that five of the six 
participants were not registered on the NSP and were missed opportunities for this 
nutrition intervention. The other participants (83%) had to be referred to the NSP 
by the investigator. The one participant that was registered with the NSP received 
and used her products as she was instructed.  
 
Ninety-three per cent (n = 70) of the participants who were eligible for a follow-up 
visit, received their micronutrients folate and iron, with 7% not being issued with 
their micronutrient supplementation. Nausea, constipation and heartburn were 
some of the complaints that 26% (n = 18) of participants raised when taking the 
micronutrients.   
 
5.2 RECOMMENDATIONS 
I. The adequacy of human resources, such as health care workers, should be 
investigated at these clinics. More health care workers can reduce the work 
load, leading to more time available to provide quality antenatal care with 
pregnant women. 
II. Training of health care workers may familiarise them with the NSP and in 
particular the entry criteria for pregnant women into the NSP.  
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III. Consideration should be given to updating the BANC activity checklist (used 
at clinics by nursing personnel) to include measurement of the MUAC and 
to include a section on referring identified undernourished patients to a 
dietician or nutrition counsellor. This could help nursing personnel to 
remember to screen for undernutrition and help patients to be referred to 
the appropriate personnel to enter them into the NSP.  
IV. Training should be extended to health care professionals (e.g. social 
workers) working in the community and not only those working at public 
facilities. This would help to identify possible clients that could benefit from 
the NSP that were not noted by the nursing staff.   
V. More effort could be made to inform pregnant women about the NSP-food, 
vitamin A-, folate- and iron supplementation. Possible ways of 
communication are pamphlets, posters at the clinics and hospitals, 
advertisements on television and radio interviews.   
 
5.3 LIMITATIONS 
Limitations of the study include the following: 
I. During data collection, xenophobic attacks were prominent in the 
investigation areas, which may explain the low number of participants 
attending the clinics.   
II. The questionnaire did not make provision for participants to comment on 
where they had heard about the NSP food-, vitamin A-, folate- and iron 
supplementation, even if they were not using the particular supplement 
currently. This could have helped to determine which resources the 
government can focus on to inform the general population about 
interventions in place to improve pregnancy outcomes. 
III. This study did not include a staff component that investigated nursing 
personnel’s awareness, insight and experience regarding the nutritional 
supplementation programmes offered to pregnant women at the clinics. 
This could have help to explain some of the findings of the study. 
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APPENDIX A 
INFORMATIVE LETTER SENT OUT TO PARTICIPATING CLINICS 
   
Tygerberg, February  2008 
 
Evaluation of Selected Components of Health Facility-Based Nutrition Programmes 
in the Western Cape Province of South Africa 
 
The purpose of this correspondence is to inform you of a planned audit of the Nutrition 
Supplementation Programme (NSP). The Sub-Directorate: Nutrition of the Western Cape 
Department of Health supports this NSP audit. 
 
The aim of this audit is to examine nutritional supplementation programmes (NSP) offered 
at primary health clinics (PHC) in the Western Cape Province.  
 
The study/audit will identify implementation barriers, inefficiencies and successes in the 
nutrition supplementation programme, and thus serve as a basis for improvement.     
 
The study was approved by the Human Research Committee and the research committee 
of the Department of Health. The Division of Human Nutrition at Stellenbosch University 
will coordinate the study with the cooperation of the Department of Health, Sub 
Directorate nutrition.  
 
Field-workers and master students in clinical nutrition will undertake the practical part of 
the study. We started the study in December 2007. The practical work including 
explanations of the study to the clients, obtaining their written consent, interview, 
measurements (will bring our own scales) etc. will be performed by the field-workers and 
master students in order not to impose additional burden on the clinic staff.  We will clarify 
with the staff when it will be most convenient for them to participate during our visit.   
 
The target groups will be clients during their PHC visits as well as PHC staff members.   
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The following methods will be used: 
 
 Anthropometry to assess nutrition-related variables amongst the target 
groups. 
 Identify the knowledge and compliance among the target adults in relation to 
these programmes by interviewing them.  
 Among the PHC staff knowledge, allocated resources and compliance with 
implementation of these supplementation programmes (using structured 
interviews and questionnaires) will be determined. 
 In a subset of clients blood samples will be collected for analysis of nutrients 
and inflammatory parameters. Note: We will specifically address this issue to 
selected PHCs only. 
 
All collected data and information will be treated with confidentiality and neither individual 
PHCs, clients nor staff members will be identified in data reporting. After completion of the 
study a report will be presented to the Department of Health and all relevant authorities. 
 
Before the planned study is initiated, further practical and logistic arrangements will be 
made with the facility manager. 
 
Should you have any further queries at this stage, please do not hesitate to contact us, 
see details below. 
 
Yours faithfully, 
 
Marietjie Herselman, Assoc Professor  
Acting Head, Div Human Nutrition, University of Stellenbosch  
(e-mail: mgh@sun.ac.za, ph: 021-938 9256) 
 
Per Ole Iversen, MD Visiting Professor at the Div. of Human Nutrition 
University of Oslo, Norway 
(e-mail: poiversen@hotmail.com, ph: 021 938 9474) 
 
DEPARTMENT OF HEALTH, WESTERN CAPE 
HILARY GOEIMAN, DEPUTY DIRECTOR INTEGRATED NUTRITION PROGRAMME, 
(E-MAIL: HGOEIMAN@PGWC.GOV.ZA, PH: 021 483 5663) 
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APPENDIX B 
QUESTIONNAIRE– AFRIKAANS 
Deel A: Sosiodemografiese data 
Swanger vrou  
 
Datum van onderhoud: (DD/MM/JJJJ): 
Veldwerker (voorletters): 
Naam en nommer van kliniek: 
Soort kliniek:  PGK    ARVK 
 
Vir die veldwerker: 
1. Antropometrie (swangerskap data):   
Gestasie (weke):___________ 
Groei volgens symphysis-fundus grafiek:    Voldoende     Onvoldoende  
  Nie beskikbaar 
Middel bo-arm omtrek:  _________cm 
2. Vir watter soort aanvulling kom sy in aanmerking? 
 Vitamien A     Voedingsaanvulling     Mikronutrient-aanvulling 
3. Is hierdie aanvulling in die protokol van die Voedingsaanvullingsprogram of 
êrens anders geregistreer?     Ja   Nee (spesifiseer as nie in 
Voedingaanvullingsprogram geregistreer is nie):  
______________________________________________________ 
4. Huidige chroniese siektes1 (indien geregistreer):    
   MIV/vigs (of aangeteken as RVS)      TB     Ander (spesifiseer):  
 
1) Chroniese siektes waarna as “Sekere chroniese siektes” verwys word in die 
beleid- en implementeringsriglyne van die Voedingsaanvullingsprogram, wat deel 
uitmaak van die Gesondheidsfasiliteitgebaseerde Voedingsprogram (2007): 
chroniese diarree, sistiese fibrose, onkologiese siekte, chroniese longsiekte, 
aangebore hartsiekte, vroeggebore babas, chroniese lewersiekte, niersiekte, 
disfagie/lewensgevaarlike aspirasie, aangebore metabolismegebrekke, ander bv. 
kind of moeder gediagnoseer met uiters middelweerstandige of 
veelmiddelweerstandige TB.
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Vrae aan vrou: 
5. Geboortedatum (DD/MM/JJJJ):  _______________ 
            Ouderdom (jaar):  ______________ 
6. Gesinsverband:   
 Getroud     Geskei     Weduwee     Woon saam, ongetroud    
 Woon alleen 
7. Getal kinders om voor te sorg:     
  0    1     2      3–4      > 5  
8. Hoeveel mense woon in u huis/in dieselfde huis as u? __________persone 
Wie?: _______________________________________________________ 
9. Bevolkingsgroep:   
      Swart        Kleurling        Indiër        Wit           Ander: _______________ 
10. Voltooide opvoeding:   
 Geen      Laerskool      Graad 8–10      Graad 11–12      Tersiêr   
11. Werkstatus:  
 Tuis met kinders    In eie diens    Loontrekker    
 Ander (spesifiseer):  ________________________________________ 
12. Totale maandelikse inkomste van huishouding:   
 Geen    R1–R500     R501–R1000     R1001–R3000    
 R3001–R5000  > R5 001     Weet nie   
13. Ontvang u/u gesin toelaes?    
 Nee    Kindertoelae     Maatskaplike bystand 
 ongeskiktheidspensioen   Ouderdomspensioen     Van familie  
  Ander (spesifiseer):  _______________________________________ 
14. Geld wat weekliks aan kos bestee word:      
 R0–R100     R101–R200     R201–R400    >R401 
15. Soort behuising: 
  Baksteen of beton     Tradisionele modder     Sinkplaat     
 Plank/hout   Ander (spesifiseer): _____________________________ 
16. Waar kry u meestal drinkwater vandaan? 
 Eie kraan     Gemeenskaplike kraan     Rivier, dam    
 Boorgat, put   Ander (spesifiseer): ___________________________ 
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17. Watter soort toilet het u huishouding? 
 Spoel     Put of verbeterde-ventilasieput      Emmer of pot    
 Geen  Ander (spesifiseer): _________________________________ 
18. Borsvoedingspraktyk:    
A. Beplan u om u kind te borsvoed?     Ja      Nee  
B. Indien nie, waarom?    Nie bewus van gesondheidsvoordele nie    
 Nie goed vir my figuur nie    Formule is beter    My man laat dit nie 
toe nie      Sal nie by die werk kan borsvoed nie    Het nog nie daaroor 
gedink nie    Ander (spesifiseer):  ______________________________ 
C. Indien wel, vir hoe lank beplan u om te borsvoed?  
___________________________________________________________ 
 
Deel B: Aanvulling 
Swanger vrou  
 
Datum van onderhoud: (DD/MM/JJJJ): 
Veldwerker (voorletters): 
Naam en nommer van kliniek: 
Soort kliniek:  PGK    ARVK   
 
19. Waarom besoek u vandag die kliniek? 
 Opvolg besoek vir swangerskap     Om aanvullings te kry     Siekte  
 Ander (spesifiseer): 
______________________________________________ 
20. Het u gehoor van enige van hierdie voedingsaanvullings wat by hierdie 
kliniek aangebied word?    
  Vitamien A-aanvullings     Voedingsaanvullings (drankies, 
ontbytgrane, ens.) 
   Mikrovoedingstowwe (wat folaat en yster insluit)     Nee 
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21. Het u al enige van hierdie aanvullings gesien? (Wys die kliënt die boksie 
met die vitamien A-kapsules, die vitamien A-kapsule self en voorbeelde van 
voedings- en mikrovoedingstof-aanvullings) 
  Vitamien A      Voedingsaanvullings      Mikrovoedingstowwe         
 Nee 
INDIEN NIE, LOS DIE RES VAN DIE VRAE. 
22. Het u enige van hierdie vir eie gebruik ontvang?       
  Nee       Ja       Kan nie onthou nie 
23. Indien wel, watter soort aanvulling het u ontvang?     
 Vitamien A   
– DOEN DIE AFDELING “DIE VITAMIEN A-AANVULLING”. 
 Voedingsaanvullings (drankies, ontbytgrane, ens.)  
– DOEN DIE AFDELING “DIE VOEDINGSAANVULLING”. 
 Mikrovoedingstof-aanvulling (wat folaat en yster insluit) 
– DOEN DIE AFDELING “DIE MIKROVOEDINGSTOF-AANVULLING”. 
24. Indien nie, het u enige mening oor wat die rede daarvoor kan wees? 
 Nee     Ja (spesifiseer): ____________________________________ 
 
Die vitamien A-aanvulling 
25. Weet u hoekom u ŉ vitamien A-aanvulling ontvang het? 
 Nee     Ja (spesifiseer): ____________________________________ 
26. Kan u onthou wanneer u die vitamien A-aanvulling ontvang het? 
 Nee     Ja (spesifiseer, maande): _____________________________ 
27. Het u die vitamien A-kapsule by die kliniek gedrink? 
 Ja    Nee (spesifiseer): _____________________________________ 
28. Indien u ŉ vitamien A-aanvulling ontvang het, wie het dit vir u gegee? 
  Professionele/geregistreerde verpleegkundige/suster 
 Verpleegpersoneel  Dieetkundige     
 Ander (spesifiseer): _________________________________________ 
29. Het enige iemand met u oor ŉ vitamien A-aanvulling gepraat? 
 Nee   Ja (spesifiseer): _____________________________________ 
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30. Indien ’n lid van die kliniekpersoneel met u oor ŉ vitamien A-aanvulling 
gepraat het, wie was dit?     Professionele/geregistreerde 
verpleegkundige/suster  Verpleegpersoneel  Dieetkundige    
 Ander (spesifiseer):  ______________________________________ 
31. Hoe het u u gesprek met hierdie personeellid ervaar? 
 Nuttig   Verwarrend  
 Geeneen van die voorafgaande nie (spesifiseer):  ________________ 
32. Het u enige skriftelike inligting (soos ’n voubiljet, ens.) oor u vitamien A-
aanvulling ontvang?    Nee   Ja   
Indien wel, het u dit as nuttig ervaar?   Nee     Ja  
33. Het u enige probleme met die neem van die vitamien A-aanvulling 
ondervind?  Nee   Ja (spesifiseer): ___________________________ 
34. Het u enige newe-effekte van die vitamien A-aanvulling ondervind?  
 Nee   Ja (spesifiseer): _____________________________________ 
 
Die voedingsaanvulling  
35. Weet u hoekom u die voedingsaanvulling ontvang het? 
 Nee     Ja (spesifiseer): ____________________________________ 
36. Het u enige raad oor eetgewoontes ontvang voordat u die 
voedingsaanvulling ontvang het?    Nee  Ja (spesifiseer): _________ 
37. Wie het die aanvulling vir u gegee? 
Professionele/geregistreerde verpleegkundige/suster 
 Verpleegpersoneel   Dieetkundige   Ander (spesifiseer): _________ 
38. Neem u die voedingsaanvulling soos die personeellid gesê het u dit moet 
doen (of het u dit so geneem)?    Ja    Nee (spesifiseer): ___________ 
39. Het enigiemand met u oor ŉ voedingsaanvulling gepraat? 
  Nee     Ja (spesifiseer): ___________________________________ 
40. Indien ’n lid van die kliniekpersoneel met u oor ŉ voedingsaanvulling 
gepraat het, wie was dit?   
  Professionele/geregistreerde verpleegkundige/suster    
 Verpleegpersoneel   Dieetkundige    Ander (spesifiseer): 
_________ 
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41. Hoe het u u gesprek met hierdie personeellid ervaar?   
  Nuttig   Verwarrend  Geeneen van die voorafgaande nie 
(spesifiseer):  ________________________________________________ 
42. Het u enige skriftelike inligting (soos ’n voubiljet, ens.) oor u 
voedingsaanvulling ontvang? 
  Nee   Ja   Indien wel, het u dit as nuttig ervaar?    Nee    Ja 
43. Het u enige probleme met die neem van die voedingsaanvulling ondervind?  
  Nee    Ja (spesifiseer): __________________________________ 
44. Het u enige newe-effekte van die voedingsaanvulling ondervind?  
    Nee     Ja (spesifiseer): _________________________________ 
45. Deel u ooit die voedingsaanvulling met enige lede van u huishouding?  
 Nee    Ja (spesifiseer): ___________________________________ 
46. Het u ooit die voedingsaanvulling verkoop om geld te kry om ander items 
mee te koop?  
  Nee   Ja (spesifiseer): ____________________________________ 
Die mikrovoedingstof-aanvulling 
47. Weet u hoekom u ŉ mikrovoedingstof-aanvulling ontvang het? 
   Nee     Ja (spesifiseer): __________________________________ 
48. Kan u onthou wanneer u die mikrovoedingstof-aanvulling ontvang het? 
     Nee     Ja (spesifiseer, weke): ____________________________ 
49. Indien u ŉ mikrovoedingstof-aanvulling ontvang het, wie het dit vir u 
gegee? 
 Professionele/geregistreerde verpleegkundige/suster  
 Verpleegpersoneel  Dieetkundige    
 Ander   (spesifiseer): ________________________________________ 
50. Het enigiemand met u oor ŉ mikrovoedingstof-aanvulling gepraat? 
  Nee   Ja (spesifiseer): ____________________________________ 
51. Indien ’n lid van die kliniekpersoneel met u oor mikrovoedingstof-aanvulling 
gepraat het, wie was dit?     Professionele/geregistreerde 
verpleegkundige/suster   Verpleegpersoneel   Dieetkundige   
   Ander (spesifiseer):  _______________________________________ 
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52. Hoe het u u gesprek met hierdie personeellid ervaar? 
Nuttig Verwarrend  
 Geeneen van die voorafgaande nie (spesifiseer):  _________________ 
53. Het u enige skriftelike inligting (soos ’n voubiljet, ens.) oor u 
mikrovoedingstof-aanvulling ontvang?     Nee   Ja    
Indien wel, het u dit as nuttig ervaar?       Nee    Ja  
54. Het u enige probleme met die neem van die mikrovoedingstof-aanvulling 
ondervind?  
  Nee   Ja (spesifiseer): ____________________________________ 
55. Het u enige newe-effekte van die mikrovoedingstof-aanvulling ondervind?  
  Nee   Ja (spesifiseer): ____________________________________ 
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APPENDIX C 
QUESTIONNAIRE – ENGLISH 
 
Part A: Socio-demographic data 
 Pregnant woman  
Date of interview (DD/MM/YYYY): 
Field worker (initials): 
Name and number of this clinic: 
Type of clinic: PHC    ARVC 
 
For the field worker: 
1. Anthropometry (pregnant data):     
Weeks gestation:  ___________ 
Growth according to symphysis-fundus graph:     
  Sufficient      Insufficient     Not available  
Mid upper arm circumference:  _________cm 
2. For what type of supplementation is she eligible? 
  Vitamin A    Nutrition supplementation     Micronutrient 
supplementation 
3. Is this supplementation registered in the Malnutrition Register or elsewhere?    
  Yes        No (specify if not in Malnutrition Register): _________________ 
4. Present chronic disease1 (if recorded):    
   HIV/AIDS (or noted as RVD)   TB     Other (specify): ____________ 
 
1) Chronic diseases referred to as “Certain Chronic diseases” in Policy and 
Implementation Guidelines for the Nutrition Supplementation Program of the 
Health Facility Based Nutrition Programme (2007): Chronic diarrhea, cystic 
fibrosis, oncological disease, chronic lung disease, congenital cardiac disease, 
premature infants, chronic liver disease, renal disease, dysphagia/life 
threatening aspiration, inborn errors of metabolism, others e.g. infant of mother 
diagnosed with XDR of MDR. 
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Questions to woman: 
5. Date of birth  (DD/MM/YYYY):  ________________ 
      Age (years):__________ 
6. Family relation:   
 Married  Divorced   Widow  Living together, not married   
 Living alone 
7. Number of children to support:     
 0     1     2       3 -4     > 5  
8. How many persons are living in your home/in the same house as you? 
___________persons. Who? : _____________________________________ 
9. Population group:      
            Black          Colored         Indian          White         Other:  ______________ 
10. Completed education:   
  None      Primary school     Grade 8-10   Grade 11-12    Tertiary   
11. Working status:  
 Home with children  Self-employed  Wage earner   
 Other (specify): _______________________________________________ 
12. Total household income per month:   
 None       R1-500       R501-1000       R1001-3000       R3001-
5000    
> R5001    Do not know   
13. Do you/your family receive grants:    
 No    Child support    Social relief    Disability    Old age pension  
  From family  Other (specify): __________________________________ 
14. Money spent on food weekly:     
 R0-100    R101-200    R201-400  >R401 
15. Type of housing: 
Brick or concrete Traditional mud    Tin   Plank/wood  
 Other (specify):  _______________________________________________ 
16. Where do you get drinking water most of the time: 
 Own tap   Communal tap   River, dam   Borehole, well  
 Other (specify):  _______________________________________________ 
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17. What type of toilet does this household have: 
Flush   Pit or VIP    Bucket or pot   None   Other (specify): ______ 
 
18. Breastfeeding practice:    
A. Do you plan to breastfeed your child?   Yes      No 
B. If not, why?    Not aware of its health benefits      It spoils my figure    
 Formulas are better  Not permitted by husband   Will not be able to 
breastfeed at work   Haven’t thought about it yet  
 Other (specify): ______________________________________________ 
C. If Yes, for how long do you plan to breastfeed? _________________________ 
 
Part B: Supplementation 
Pregnant woman  
Date of interview (DD/MM/YYYY): 
Field worker (initials): 
Name and number of this clinic: 
Type of clinic:   PHC    ARVC   
 
19. Why are you visiting the clinic today? 
 Follow-up visit for pregnancy     To receive supplementation      
 Disease    Other (specify): _________________________________ 
20. Have you heard about any of these nutritional supplementation offered at 
this clinic?    
  Vitamin A supplements   Nutrition supplements (drinks, infant 
formulas, cereals etc.)  Micronutrients (including folate and iron)     No 
21. Have you seen any of these supplements? (Show the client the box with 
vitamin A capsules, the vitamin A-capsule itself and examples of nutrition 
and micronutrient supplements) 
  Vitamin A    Nutrition supplements    Micronutrients      No  
IF NO, SKIP REST OF QUESTIONS 
22. Have you received any of these for yourself?       
   No       Yes  Do not remember  
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23. If yes, what type of supplementation have you received?     
 Vitamin A   
-DO THE SECTION “THE VITAMIN A SUPPLEMENTATION” 
 Nutrition supplements (drinks, infant formulas, cereals etc.)  
–DO THE SECTION “THE NUTRITION SUPPLEMENTATION” 
 Micronutrient supplementation (including folate and iron) 
–DO THE SECTION “THE MICRONUTRIENT SUPPLEMENTATION” 
24. If no, do you have any opinion of what the reason for this may be? 
 No     Yes (specify): ____________________________________ 
 
The vitamin A supplementation 
25. Do you know why you have received vitamin A supplementation? 
 No     Yes (specify): ______________________________________ 
26. Do you remember when you received vitamin A supplementation? 
 No     Yes (specify, months): _______________________________ 
27. Did you take the vitamin A capsule at the clinic? 
 Yes    No (specify): ______________________________________ 
28. If you received vitamin A supplementation, who gave it to you? 
  Professional/registered nurse/sister   Nursing staff   Dietician  
 Other (specify): ___________________________________________ 
29. Has anyone talked to you about vitamin A supplementation? 
 No   Yes (specify): _______________________________________ 
30. If a member of the clinic staff has talked to you about vitamin A 
supplementation, who talked to you?    Professional/registered 
nurse/sister   Nursing staff    Dietician   Other: ________________ 
31. Talking to this staff member, did you find it: 
Helpful     Confusing     None of the above (specify): ___________ 
32. Have you received any written information (like a flyer etc) about your 
vitamin A supplementation?    No  Yes   
If Yes, did you find it useful?   No    Yes  
33. Have you experienced any problems taking the vitamin A supplementation? 
 No   Yes (specify): _______________________________________ 
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34. Have you experienced any side-effects with the vitamin A 
supplementation?  No   Yes (specify): _________________________ 
 
The nutrition supplementation  
35. Do you know why you have received the nutrition supplementation? 
 No     Yes (specify): ______________________________________ 
36. Did you get any advice concerning food habits before you got the nutrition 
supplementation? 
 No     Yes (specify): ______________________________________ 
37. Who gave the supplementation to you? 
  Professional/registered nurse/sister  Nursing staff   Dietician   
 Other (specify): ____________________________________________ 
38. Do/did you take the nutrition supplement as this staff member told you to? 
 Yes    No (specify): _______________________________________ 
39. Has anyone talked to you about nutrition supplementation? 
 No     Yes (specify): ______________________________________ 
40. If a member of the clinic staff has talked to you about nutrition 
supplementation, who talked to you? 
  Professional/registered nurse/sister  Nursing staff Dietician  
 Other (specify): ____________________________________________ 
41. Talking to this staff member, did you find it:   
 Helpful   Confusing  None of the above (specify): 
_______________ 
42. Have you received any written information (like a flyer, etc) about your 
nutrition supplementation?     No  Yes   
If Yes, did you find it useful?  No    Yes 
43. Have you experienced any problems taking the nutrition supplementation?  
 No    Yes (specify): _______________________________________ 
44. Have you experienced any side-effects with the nutrition supplementation?  
  No     Yes (specify): ______________________________________ 
45. Is the nutrition supplementation ever shared with any members of your 
household?  No    Yes (specify): ______________________________ 
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46. Have you ever sold the nutrition supplement to get money to buy other 
items?  No   Yes (specify): 
___________________________________ 
 
The micronutrient supplementation 
47. Do you know why you have received micronutrient supplementation? 
 No     Yes (specify): _______________________________________ 
48. Do you remember when you received micronutrient supplementation? 
 No     Yes (specify, weeks): ________________________________ 
49. If you received micronutrient supplementation, who gave it to you? 
  Professional/registered nurse/sister  Nursing staff   Dietician  
Other (specify): ____________________________________________ 
50. Has anyone talked to you about micronutrient supplementation? 
 No  Yes (specify): _________________________________________ 
51. If a member of the clinic staff has talked to you about micronutrient 
supplementation, who talked to you? 
  Professional/registered nurse/sister  Nursing staff Dietician 
 Other (specify): ____________________________________________ 
52. Talking to this staff member, did you find it:  
Helpful   Confusing  None of the above (specify): ______________ 
53. Have you received any written information (like a flyer etc) about your 
micronutrient supplementation?     No  Yes    
If Yes, did you find it useful?          No    Yes  
54. Have you experienced any problems taking the micronutrient 
supplementation?  
 No   Yes (specify): _______________________________________ 
55. Have you experienced any side-effects with the micronutrient 
supplementation?  No   Yes (specify): _________________________ 
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APPENDIX D 
QUESTIONNAIRE – XHOSA 
 
Icandelo A: Iinkcukacha-manani  
 Umama okhulelweyo 
Umhla wodliwano-ndlebe (DD/MM/YYYY):  
Umsebenzi owenza uphando (oonobumba bokuqala bamagama akho): 
Igama nenombolo yale kliniki: 
Uhlobo lwekliniki:  iPHC    i-ARVC 
 
Oku kwenzelwe umsebenzi owenza uphando: 
1. Izifundo zokujonga imilinganiselo yomzimba womntu (ingxelo egciniweyo 
ungakhulelewanga):  
Zingaphi iinyanga ukhulelwe:  ________________ 
Umntwana ukhula ngomlinganiselo oqingqiweyo na:   
  kakuhle ngoko mlinganiselo 
  ngokungekho mlinganiselweyo 
  akukho mlinganiselo 
Ubukhulu besiphanga:  _________cm  
2. Ulungele ukufumana luhlobo luni  lwezongezelelo ? 
uVitamin A   izongezelelo zezondlo     izongezelelo zezakha-mzimba  
3. Ingaba ezi zongezelelo zibhaliswe ngokusesikweni kwiNSP protocol okanye 
endaweni ethile? Ewe   Hayi 
4. Isifo anaso esiphela ngokufa1 (ukuba sisezincwadini):    
  iHIV/AIDS (okanye esiqondwa njengeRVD)  iTB   Esinye (cacisa): 
_____________________________________________________________ 
1) Izifo eziphelela ekufeni nekubhekiswa kuzo njenge “Zifo ezithile eziphelela 
ekufeni” kuMgaqo-nkqubo nokuSetyenziswa koMkhomba-ndlela kwiNkqubo 
yeZongezelelo zeZondlo eziQhutyelwa kumaZiko (2007): Utyatyazo oluyingozi, 
ukukrala kwemiphunga, isifo samathumba, isifo semiphunga esiyingozi, isifo 
sentliziyo kwasesizalweni, iintsana ezivela phambi kwexesha , isifosesibindi 
esiyingozi, isifo sezintso, ukungakwazi ukuginya/isifo esinokudala ukufa, 
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iingxaki zokwetyisa kwasesizalweni, ezinye umz.umama womntwana onesifo  
iXDR yeMDR. 
 
Imibuzo eya kumama: 
5. Umhla wokuzalwa  (DD/MM/YYYY):  _________________ 
Ubudala (iminyaka):  ________________ 
6. Unxulumano losapho:    
Utshatile  Uqhawulo-mtshato  Umhlolokazi  
 Nihlala kunye, anitshatanga  Uhlala wedwa  
7. Inani labantwana obondlayo:     
  0     1    2   3 – 4 > 5  
8. Bangaphi abantu abahlala kwikhaya lakho/kwindlu ohlala kuyo?  ___________ 
Ngoobani? ____________________________________________________ 
9. Uhlanga:  
      oMnyama         oweBala           uMndiya          Omhlophe          Okunye      
10. Imfundo oyigqibileyo:  
Ayikho     Amabanga aphantsi iBakala lesi-8 – 10 
 Ibakala le-11 – 12 Imfundo enomsila   
11. Ubume bomsebenzi: 
Uhlala ekhaya nabantwana   Uziqeshile    Ufumana umvuzo   
Ezinye (cacisa):_______________________________________________ 
12. Imali engenayo kusapho ngenyanga:   
Ayikho   R1 – R500 R501 – R1000 R1001 – R3000 
R3001 – R5000 > R5001     Andazi   
13. Ingaba wena/usapho lwakho nifumana izibonelelo zegranti? 
Hayi Inkxaso-mali yabantwana Uncedo lwentlalo 
Eyokugogeka ilungu Inkamnkam   Esuka kusapho  
 Okunye (cacisa): ____________________________________________ 
14. Imali echithwayo ekutyeni rhoqo ngeveki: 
R0 – R100 R101 – R200 R201 – R400 >R401 
15. Uhlobo lwendlu: 
Yenziwe ngezitena okanye isamente Yenziwe ngodaka 
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 Ngamankcenkce  Ngamaplanga Olunye (cacisa): 
_________________ 
16. Uwafumana phi amanzi okusela ixesha elininzi: 
Itepu yakho Itepu yomntu wonke Emlanjeni, edamini 
Ephikweni, equleni Ezinye (cacisa): ______________________________ 
17.Zeziphi izindlu zangasese ezisetyenziswa lolu sapho ? 
Zinamanzi Umgodi okanye iVIP   Amabhakethi okanye ipoti 
Ayikho  Ezinye (cacisa): ______________________________________ 
18. Ukuncancisa umntwana:   
A. Uyamncancisa/ukhe wamncancisa umntwana?   Ewe   Hayi 
B. Ukuba akumncancisi kutheni?   bendingayazi ukuba ubisi lwebele lunempilo  
kumosha isiqu sam Ubisi lwefomulalolona lungcono  umyeni wam walile  
  andikhange ndikwazi ukuncancisa emsebenzini  bendingekakucingi oko  
Okunye (cacisa):_______________________________________________ 
C.Ukuba uyancancisa, ungathatha ixesha elingakanani? ____________________ 
 
Icandelo: Izongezelelo zezondlo 
Umama okhulelweyo/oncancisayo  
Umhla wodliwano-ndlebe (DD/MM/YYYY):  
Umsebenzi owenza uphando (oonobumba bokuqala bamagama akho): 
Igama nenombolo yale kliniki: 
Uhlobo lwekliniki:  iPHC    i-ARVC 
 
19. Yintoni ekundulule ukuba uze eklinikhi namhlanje? 
 Kukuza eklinikhi komntu okhulelweyo  Kukuza kufumana izongezelelo   
 Kukugula  Okunye (cacisa): __________________________________ 
20. Zikhona izongezelelo zezakha-mzimba ezikhutshwa yile klinikhi owakhe weva 
ngazo? 
izongezelelo zikaVitamin A    izongezelelo zezakha-mzimba (iziselo, 
isiriyeli, njl.)   izakha-mzimba ezizipilisi (kuquka ne-iron)  Hayi 
21. Zikhona  izakha-mzimba owakha wazibona kwezi? (Mbonise ibhokisi eneepilisi 
ezinovitamin A, inkqu yeepilisi ezinovitamin A nemizekelo yezongezelelo 
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zezondlo nezezakha-mzimba) uVitamin A Izongezelelo zezondlo   
  Izongezelelo zezakha-mzimba   Hayi 
 
UKUBA UTHI HAYI, YITSIBE YONKE LE MIBUZO. 
 
22. Zikhona kwezi owakha wazifumana wena buqu 
 Ewe      Hayi   Andisakhumbuli 
23. Ukuba uthi ewe, zeziphi izongezelelo zezondlo owazifumanayo?     
uVitamin A    
-YENZA ICANDELO “UKONGEZWA KUKAVITAMIN A” 
 Izongezelelo zezakha-mzimba (iziselo, neesiriyeli, njlnjl) 
-YENZA ICANDELO “UKONGEZWA KWEZONDLO ” 
 Izongezelelo zezakha-mzimba (kubandakanywa ifolate ne-iron) 
-YENZA ICANDELO “UKONGEZWA KWEZAKHA-MZIMBA” 
24. Ukuba uthi hayi, ingaba unazo izizathu ezenza oku? 
 Hayi     Ewe (cacisa): ________________________________________ 
 
Izongezelelo zikaVitamin A  
25. Uyazi ukuba kutheni ufumene izinto ezinceda ukongeza uvitamin A? 
 Hayi     Ewe (cacisa): ________________________________________ 
26. Usakhumbula ukuba wazifumana nini izinto ezinceda ukongeza uvitaminA ? 
 Hayi     Ewe (cacisa, iinyanga): _________________________________ 
27. Wawusela iipilisi ezinovitamin A ekliniki? 
Ewe Hayi (cacisa): ____________________________________________ 
28. Ukuba ubuzifumene izinto ezongeza uvitamin A, ngubani owakunikayo? 
Umongikazi oyingcali/obhalisiweyo Abasebenzi kwezonyango  
Ingcali yokutya okusisondlo  Abanye (cacisa): ______________________ 
29. Ingaba ukhona umntu owakhe wathetha nawe ngezongezelelo zikavitamin A? 
 Hayi     Ewe (cacisa): _________________________________________ 
30. Ukuba umntu osebenza ekliniki wakhe wathetha nawe ngezongezelelo 
zikavitamin A, ngubani owathetha nawe?    
 Umongikazi oyingcali /obhalisiweyo  
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 Abasebenzi kwezonyango   Ingcali yokutya okusisondlo   
 Abanye (cacisa): ______________________________________________ 
31.  Ngokuthetha nalo msebenzi, ingaba oku wakufumanisa : 
Kuluncedo Kudida  Akukho nanye kwezi zingentla (cacisa): __________ 
32. Ingaba zikhona iinkcukacha ezibhaliweyo owazifumanayo (njengephetshana 
elineenkcukaca njlnjl) ngezongezelelo zikavitamin A?  Hayi  Ewe    
Ukuba uthi ewe, uye walifumanisa liluncedo?  Hayi   Ewe  
33. Wakhe wafumana iingxaki ngokusebenzisa kwakho izongezelelo zikavitamin 
A?  Hayi     Ewe (cacisa):_______________________________________ 
34. Ingaba zikhona iziphumo ezingentle ezabonakalayo kuwe ngokusebenzisa 
kwakho uvitamin A?  Hayi     Ewe (cacisa): ________________________ 
 
Ukongezwa kwesondlo esinempilo 
35. Uyazi ukuba kutheni ufumene izongezelelo zezondlo? 
Hayi   Ewe (cacisa): _________________________________________ 
36. Ingaba ukhe wacetyiswa ngokutya iindidi ezithile zokutya phambi kokuba 
ufumane izongezelelo zesondlo esinempilo    Hayi   Ewe(cacisa): ______ 
37. Ngubani okunike izongezelelo zezondlo ezinempilo? 
Umongikazi oyingcali /obhalisiweyo  Abasebenzi kwezonyango  
 Ingcali yokutya okusisondlo  Abanye (cacisa): _____________________ 
38. Uyazithatha/ wazithatha izongezelelo zezakha-mzimba njengoko eli gosa 
lalikuyalela?   Ewe    Hayi (cacisa):_______________________________ 
39. Ingaba kukho umntu owakhe wathetha nawe ngezongezelelo zezondlo? 
 Hayi   Ewe (cacisa): __________________________________________ 
40. I Ukuba umntu osebenza ekliniki wakhe wathetha nawe ngezongezelelo 
zezondlo, ngubani owathetha nawe?   
  Ingcali yomongikazi/obhalisiweyo  Abasebenzi kwezonyango  
 Ingcali yokutya okusisondlo  Abanye (cacisa): _____________________ 
41. Ngokuthetha nalo msebenzi, ingaba oku wakufumanisa:  
 Kuluncedo  Kudida  Akukho nanye kwezi zingentla (cacisa): ________ 
42. Ingaba zikhona iinkcukacha ezibhaliweyo owazifumanayo (njengephetshana 
elineenkcukaca njlnjl) ngezongezelelo zezondlo? Hayi Ewe   
Ukuba uthi ewe, uye walifumanisa liluncedo?  Hayi Ewe 
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43. Wakhe wafumana iingxaki  ngokusebenzisa kwakho izongezelelo zezondlo?  
 Hayi   Ewe (cacisa): _________________________________________ 
44. Ingaba zikhona iziphumo ezingezihle owazibonayo ngokusebenzisa kwakho 
izongezelelo zezondlo?  
  Hayi    Ewe (cacisa): ________________________________________ 
45. Ingaba ukhe wabelane namalungu osapho  ngezongezelelo zezondlo ekhaya? 
 Hayi    Ewe (cacisa): ________________________________________ 
46. Wakhe wazithengisa izongezelelo zezondlo ukuba ufumane imali yokuthenga 
ezinye izinto?  Hayi    Ewe (cacisa): ______________________________ 
 
Izongezelelo zezakha-mzimba 
47. Ingaba uyazi ukuba kutheni  unikwe  izongezelelo zezaka-mzimba? 
 Hayi    Ewe (cacisa): ________________________________________ 
48. Usakhumbula ukuba wawuzinikwe nini izongezelelo zezakha-mzimba? 
 Hayi  Ewe (cacisa, iinyanga): __________________________________ 
49. Ukuba ubufumana izongezelelo zezakha-mzimba, ubuzifumana kubani? 
Umongikazi oyingcali /obhalisiweyo  Abasebenzi kwezonyango  
 Ingcali yokutya okusisondlo  Abanye (cacisa): _____________________ 
50. Ingaba kukho umntu owakhe wathetha nawe ngezongezelelo zezakha-
mzimba?  Hayi  Ewe (cacisa): __________________________________ 
51. Ukuba umntu osebenza ekliniki wakhe wathetha nawe ngezongezelelo 
zezakha-mzimba, ngubani owathetha nawe?  
 Ingcali yomongikazi/obhalisiweyo Abasebenzi kwezonyango 
 Ingcali yokutya okusisondlo   Abanye (cacisa): ____________________ 
52. Ngokuthetha nalo msebenzi, ingaba oku wakufumanisa:  
 Kuluncedo   Kudida  Akukho nanye kwezi zingentla (cacisa): ________ 
53. Ingaba zikhona iinkcukacha ezibhaliweyo owazifumanayo (njengephetshana 
elineenkcukaca njlnjl) ngezongezelelo zezakha-mzimba?  Hayi    Ewe   
Ukuba uthi ewe, uye walifumanisa liluncedo?    Hayi    Ewe 
54. Wakhe wafumana iingxaki ngokusebenzisa kwakho izongezelelo zezakha-
mzimba?  Hayi  Ewe (cacisa): __________________________________ 
55. Ingaba zikhona iziphumo ezingentle ezabonakalayo kuwe ngokusebenzisa 
kwakho izakha-mzimba?  Hayi   Ewe (cacisa): ______________________ 
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APPENDIX E 
CONSENT FORM – AFRIKAANS 
 
 
INLIGTINGSBROSJURE VIR DEELNEMERS EN TOESTEMMINGSVORM VIR VROUE 
VAN VRUGBARE LEEFTYD 
 
TITEL VAN DIE NAVORSINGSPROJEK:  
Evaluering van voedingsaanvullingsprogramme gemik op kwesbare groepe in die Wes-
Kaapprovinsie van Suid-Afrika  
 
VERWYSINGSNOMMER:  N07/10/232 
 
HOOFNAVORSERS: 
Medeprofessor Marietjie Herselman, Waarnemende Hoof, Afdeling Menslike Voeding, 
Universiteit Stellenbosch  
Professor Demetre Labadarios, Afdeling Menslike Voeding, Universiteit Stellenbosch  
Professor Per Ole Iversen, Afdeling Menslike Voeding, Universiteit Stellenbosch 
Me Heila Grundlingh, magister student, Afdeling Menslike Voeding, Universiteit 
Stellenbosch 
 
ADRES: 
Afdeling Menslike Voeding 
Fakulteit Gesondheidswetenskappe  
Universiteit Stellenbosch  
Francie van Zijl-laan  
Tygerberg 7505 
 
TELEFOONNOMMER:  +27 21 938 9259 (Medeprofessor Marietjie Herselman) 
 
 U word genooi om aan ’n navorsingsprojek deel te neem.  Lees asseblief rustig deur 
hierdie inligting wat die besonderhede van die projek verduidelik.  Vra asseblief die 
studiepersoneel enige vrae oor enige deel van die projek wat u nie ten volle verstaan 
nie.  Dit is baie belangrik dat die inligting u heeltemal tevrede stel en dat u volkome 
verstaan wat hierdie navorsing behels en hoe u betrek kan word.  U deelname is 
heeltemal vrywillig; dit staan u dus vry om te besluit om nie deel te neem nie.  Indien 
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u téén deelname sou besluit, sal dit u geensins benadeel nie.  Dit staan u ook vry om 
u te eniger tyd aan die studie te onttrek, selfs al het u aanvanklik ingestem om deel te 
neem.  Alle inligting wat tot u teruggevoer kan word, met inbegrip van assesserings- 
en toestemmingsvorms, sal as vertroulik hanteer word en geen werklike name sal in 
enige dokument in hierdie studie gebruik word nie. Gemagtigde lede van die 
Universiteit Stellenbosch se Komitee vir Navorsingsetiek mag slegs indien nodig die 
inligting sien wat tydens die studie ingesamel is, op voorwaarde van streng 
vertroulikheid, vir doeleindes van gehaltebeheer en inspeksie. 
 
 Hierdie studie is deur die Universiteit Stellenbosch se Komitee vir 
Mensnavorsinggoedgekeur, en sal ooreenkomstig die etiese riglyne en beginsels van 
die Internasionale Verklaring van Helsinki, die Suid-Afrikaanse Riglyne vir Goeie 
Kliniese Praktyk, en die Mediese Navorsingsraad (MNR) se Etiese Riglyne vir 
Navorsing uitgevoer word. 
 
WAAROOR GAAN HIERDIE NAVORSINGSTUDIE? 
 Die hoofdoel is om die huidige voedingsaanvullingsprogramme vir kinders en hulle 
moeders/versorgers, vroue van vrugbare leeftyd en diegene met tuberkulose en/of 
MIV/vigs te evalueer.  Die studie sal hopelik tot beter implementering van hierdie 
programme tot voordeel van toekomstige ontvangers bydra.  Die studie sal by 
ongeveer 100 primêregesondheidsklinieke (PGK’s) in die Wes-Kaapprovinsie gedoen 
word.   
 In die studie sal u gevra word om vrae rakende u ondervinding van 
voedingsaanvullingsprogramme te beantwoord.  U sal klinies ondersoek word en u 
lengte, gewig en die omtrek van u arm/middel/heupe sal bepaal word.   
 
WAAROM WORD U GENOOI OM AAN DIE STUDIE DEEL TE NEEM? 
 U word genooi omdat u ’n vrou van vrugbare leeftyd is en een van die uitgesoekte 
klinieke besoek. 
 
WAT SAL U VERANTWOORDELIKHEDE WEES? 
 Indien u instem om aan die studie deel te neem, sal u met die studiepersoneel moet 
saamwerk om die vraelyste in te vul, u lengte, gewig en die omtrek van u 
arm/middel/heupe te laat bepaal.  Beantwoord asseblief die studiepersoneel se vrae 
eerlik om die akkuraatheid van die studie-uitslae te verseker.   
 
Stellenbosch University http://scholar.sun.ac.za
89 
 
 
SAL U VOORDEEL TREK UIT DEELNAME AAN HIERDIE NAVORSING? 
 U sal waarskynlik geen direkte voordeel uit deelname aan hierdie studie trek nie.  U 
deelname sal ons egter hopelik in staat stel om die suksesvolle implementering van 
voedingsaanvullingsprogramme in die Wes-Kaapprovinsie, en sodoende ook die 
gesondheidstatus van dié provinsie se bevolking, verder te verbeter. 
 
IS DAAR ENIGE RISIKO’S VERBONDE AAN U DEELNAME AAN HIERDIE 
NAVORSING? 
 Daar is geen langtermynrisiko’s nie.   
 
WIE SAL TOEGANG TOT U MEDIESE REKORDS HÊ? 
 Slegs die studiepersoneel sal toegang hê tot inligting wat tydens die studie van u 
ingesamel is, en alle inligting sal as vertroulik hanteer word.  Indien die studie-inligting 
in ’n publikasie of tesis gebruik word, sal u identiteit nie bekend gemaak word nie.   
 
WAT SAL GEBEUR IN DIE ONWAARSKYNLIKE GEVAL DAT U ’N SOORT 
BESERING OPDOEN AS ’N DIREKTE GEVOLG VAN U DEELNAME AAN HIERDIE 
NAVORSINGSTUDIE? 
 Dit is onwaarskynlik dat u as gevolg van u deelname aan hierdie studie, wat 
hoofsaaklik op vraelyste gegrond is, beseer sal word.  Indien u egter ’n studieverwante 
komplikasie opdoen, sal u vir mediese onkoste vir die behandeling van sodanige 
komplikasies vergoed word.  Die Universiteit Stellenbosch het versekeringsdekking 
wat aan internasionale vereistes voldoen in geval van ’n komplikasie as gevolg van die 
studie.   
 
SAL U BETAAL WORD OM AAN HIERDIE STUDIE DEEL TE NEEM, EN SAL DIT 
ENIGIETS KOS? 
 U sal nie betaal word om aan die studie deel te neem nie, en dit sal u niks kos nie.  
Geen bykomende kliniekbesoeke sal vir die doeleindes van hierdie studie nodig wees 
nie. 
 
IS DAAR ENIGIETS ANDERS WAT U MOET WEET OF DOEN? 
 U kan met enige van bogenoemde studiepersoneellede in verbinding tree indien u 
enige vrae omtrent die studie het. 
 Bel gerus die Komitee vir Mensnavorsing by 021 938 9207 indien u enige 
bekommernisse of klagtes het wat nie voldoende deur die personeel hanteer is nie.  
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 U sal ’n afskrif van hierdie inligtings- en toestemmingsvorm vir u eie rekords ontvang.  
 
VERKLARING DEUR DEELNEMER 
Deur hier onder te teken, stem ek. …………………………………..…………., in om aan ’n 
navorsingstudie getiteld Evaluering van voedingsaanvullingsprogramme gemik op 
kwesbare groepe in die Wes-Kaapprovinsie van Suid-Afrika deel te neem. 
Ek verklaar dat: 
 
 ek hierdie inligtings- en toestemmingsvorm gelees het of dat dit aan my gelees is, 
en dat dit geskryf is in ’n taal waarin ek vlot en gemaklik is; 
 ek die geleentheid gehad het om vrae te vra en dat al my vrae voldoende 
beantwoord is;  
 ek verstaan dat deelname aan hierdie studie vrywillig is en dat daar geen druk op 
my geplaas word om deel te neem nie; 
 ek kan kies om die studie te eniger tyd te verlaat sonder dat ek op enige manier 
gestraf of benadeel sal word; en 
 ek gevra kan word om die studie te verlaat voordat dit afgehandel is, indien die 
studiepersoneel voel dat dit vir my eie beswil is, of indien ek nie die studieplan 
volg soos ooreengekom is nie.  
 
 
Geteken te (plek) ......................…........…………….. op (datum) …………....……….. 
 
 ...................................................................   ................................................................. 
Handtekening van deelnemer Handtekening van getuie 
 
VERKLARING DEUR NAVORSER 
Hiermee verklaar ek, ……………………………………………..………(naam), dat: 
 
 ek die inligting in hierdie dokument aan ………………………………….. verduidelik 
het; 
 ek hom/haar aangemoedig het om vrae te vra en genoeg tyd geneem het om die 
vrae te beantwoord; 
 ek tevrede is dat hy/sy alle aspekte van die navorsing, soos hierbo bespreek is, 
voldoende verstaan; en 
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 ek ’n tolk gebruik het/nie ’n tolk gebruik het nie.  (Indien ’n tolk gebruik is, moet die 
tolk die verklaring hier onder onderteken.) 
 
Geteken te (plek) ......................…........…………….. op (datum) …………....………..  
 
 ...................................................................   ................................................................. 
Handtekening van navorser Handtekening van getuie 
 
VERKLARING DEUR TOLK 
Hiermee verklaar ek, ……………………………………………..………(naam), dat: 
 
 ek die navorser, ……………………………………….(naam), gehelp het om die 
inligting in hierdie dokument met behulp van Afrikaans/Xhosa as taalmedium aan 
……………..…………………………….. (naam van deelnemer) te verduidelik; 
 ons hom/haar aangemoedig het om vrae te vra en genoeg tyd geneem het om die 
vrae te beantwoord; 
 ek ’n feitelik korrekte weergawe van wat aan my deurgegee is, oorgedra het; en 
 ek tevrede is dat die deelnemer die inhoud van hierdie 
ingeligtetoestemmingsdokument ten volle verstaan en dat al sy/haar vrae 
voldoende beantwoord is.  
 
 
Geteken te (plek) ......................…........…………….. op (datum) …………....………..  
 
 ...................................................................   ................................................................. 
Handtekening van tolk Handtekening van getuie 
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APPENDIX F 
CONSENT FORM – ENGLISH 
 
 
PARTICIPANT INFORMATION LEAFLET AND CONSENT FORMFOR WOMEN OF 
CHILDBEARING AGE 
 
TITLE OF THE RESEARCH PROJECT:  
Evaluation of Nutritional Supplementation Programmes Targeting Vulnerable Groups in 
the Western Cape Province of South Africa.   
 
REFERENCE NUMBER: N07/10/232 
 
PRINCIPAL INVESTIGATORS: 
Assoc. Professor Marietjie Herselman, Acting Head, Div. of Human Nutrition, Stellenbosch 
University, Professor Demetre Labadarios, Div. of Human Nutrition, Stellenbosch 
University and Professor Per Ole Iversen, Div. of Human Nutrition, Stellenbosch 
University. 
ADDRESS: 
Division of Human Nutrition 
Faculty of Health Sciences, Stellenbosch University,  
Francie van Zijl Avenue,  
Tygerberg, 7505 
 
CONTACT NUMBER: +2721 938 9259 (Assoc. Professor Marietjie Herselman) 
 
 You are being invited to take part in a research project. Please take some time to 
read the information presented here, which will explain the details of this project.  
Please ask the study staff any questions about any part of this project that you do 
not fully understand. It is very important that you are fully satisfied and that you 
clearly understand what this research entails and how you could be involved.  
Also, your participation is entirely voluntary and you are free to decline to 
participate. If you say no, this will not affect you negatively in any way whatsoever.  
You are also free to withdraw from the study at any point, even if you do agree to 
take part. All information that can be traced back to you, including assessment and 
consent forms will be kept confidential and no real names will be used in any 
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documents on this study. Authorized members of the Stellenbosch University’s 
Research Ethics Committee may see the information collected during the study, 
under conditions of strict confidentiality, for reasons of quality control and 
inspection only if necessary. 
 
 This study has been approved by the Committee for Human Research at 
Stellenbosch University and will be conducted according to the ethical guidelines 
and principles of the international Declaration of Helsinki, South African Guidelines 
for Good Clinical Practice and the Medical Research Council (MRC) Ethical 
Guidelines for Research. 
 
WHAT IS THIS RESEARCH STUDY ALL ABOUT? 
 The main purpose is to evaluate the current nutrition supplementation programmes 
for children and their mothers/caregivers, women of childbearing age and those 
suffering from tuberculosis and/or HIV/AIDS. The study will hopefully contribute to 
an improved implementation of these programmes to the benefit of future 
recipients. The study will be conducted at about 100 Primary Health Clinics (PHC) 
in the Western Cape Province.  
 In the study you will be asked to answer questions concerning your experience 
participating in nutrition supplementation programmes. A maximum of 25 ml of 
blood (approximately 5 teaspoons) will be collected from you during the visit to the 
clinic to check your nutritional status. You will be examined clinically. In addition, 
measurements of length/height, body weight and arm/waist/hip circumferences will 
be taken. 
 
WHY HAVE YOU BEEN INVITED TO PARTICIPATE? 
 You have been invited to participate because you are a woman of childbearing age 
visiting one of the chosen clinics. 
 
WHAT WILL YOUR RESPONSIBILITIES BE? 
 If you agree to participate in this study you will be expected to cooperate with the 
study staff on the completion of questionnaires, measurements of length/height, 
body weight and arm/waist/hip circumferences, and drawing of blood.  Please be 
honest when answering questions by the study staff to ensure accuracy of the 
study results.  
  
Stellenbosch University http://scholar.sun.ac.za
94 
 
 
WILL YOU BENEFIT FROM TAKING PART IN THIS RESEARCH? 
 You may have no immediate benefit from participating in this study. However, your 
participation will hopefully enable us to further improve the successful 
implementation of supplementation programmes in the Western Cape Province 
and thereby the health status of its population. 
 
ARE THERE ANY RISKS INVOLVED IN YOUR TAKING PART IN THIS RESEARCH? 
 There are no long-term risks involved, but some people experience that the blood 
sampling procedure may be a bit painful. This pain is normally of short duration, 
and the volume of the blood sample is small. 
 
WHO WILL HAVE ACCESS TO YOUR MEDICAL RECORDS? 
 Only the study staff will have access to information collected from you during the 
study, and all information will be handled confidentially. If it is used in a publication 
or thesis, your identity will remain anonymous.   
 
WHAT WILL HAPPEN IN THE UNLIKELY EVENT OF SOME FORM INJURY 
OCCURRING AS A DIRECT RESULT OF YOUR TAKING PART IN THIS RESEARCH 
STUDY? 
 It is unlikely that you will get injured as a result of taking part in this study which is 
mostly based on questionnaires.  However, if you do experience a study related 
complication such as infection at the site where blood was drawn, you will be 
reimbursed for medical expenses for the treatment of complications that were 
caused by the study. Stellenbosch University has an insurance cover, which meets 
international requirements in the event of a complication arising from the study.  
 
WILL YOU BE PAID TO TAKE PART IN THIS STUDY AND ARE THERE ANY COSTS 
INVOLVED? 
 You will not be paid to take part in the study, and there will be no costs involved for 
you, if you do take part.  No additional visits to the clinic will be required for the 
purposes of this study. 
 
IS THERE ANY THING ELSE THAT YOU SHOULD KNOW OR DO? 
 You can contact any of the above mentioned study staff members if you have any 
questions concerning the study. 
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 You can contact the Committee for Human Research at phone 021-938 9207 if 
you have any concerns or complaints that have not been adequately addressed by 
the study staff. 
 You will receive a copy of this information and consent form for your own records. 
 
DECLARATION BY PARTICIPANT 
By signing below, I …………………………………..…………. agree to take part in a 
research study entitled Evaluation of Nutritional Supplementation Programmes Targeting 
Vulnerable Groups in the Western Cape Province of South Africa 
 
I declare that: 
 
• I have read or had read to me this information and consent form and it is 
written in a language with which I am fluent and comfortable. 
• I have had a chance to ask questions and all my questions have been 
adequately answered. 
• I understand that taking part in this study is voluntary and I have not been 
pressurised to take part. 
• I may choose to leave the study at any time and will not be penalised or 
prejudiced in any way. 
• I may be asked to leave the study before it has finished, if the study staff feels 
it is in my best interests, or if I do not follow the study plan, as agreed to. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....………..  
 
 ...................................................................   ................................................................. 
Signature of participant Signature of witness 
 
DECLARATION BY INVESTIGATOR 
I (name) ……………………………………………..……… declare that: 
 
• I explained the information in this document to ………………………………….. 
• I encouraged him/her to ask questions and took adequate time to answer 
them. 
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• I am satisfied that he/she adequately understands all aspects of the research, 
as discussed above 
• I did/did not use an interpreter.  (If an interpreter is used then the interpreter 
must sign the declaration below. 
 
Signed at (place) ......................…........…………….. on (date) …………....………..  
 
 ...................................................................   ................................................................. 
Signature of investigator Signature of witness 
 
DECLARATION BY INTERPRETER 
I (name) ……………………………………………..……… declare that: 
 
• I assisted the investigator (name) ……………………………………….to explain 
the information in this document to (name of participant) 
……………..…………………………….. using the language medium of 
Afrikaans/Xhosa. 
• We encouraged him/her to ask questions and took adequate time to answer 
them. 
• I conveyed a factually correct version of what was related to me. 
• I am satisfied that the participant fully understands the content of this informed 
consent document and has had all his/her question satisfactorily answered. 
 
Signed at (place) ......................…........…………….. on (date) …………....………..  
 
 ...................................................................   ................................................................. 
Signature of interpreter Signature of witness 
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APPENDIX G 
CONSENT FORM – XHOSA 
 
 
IPHETSHANA ELICHAZELA UMTHATHI-NXAXHEBA NGEENKCUKACHA 
ZOPHANDO KUNYE NEFOMU YOOMAMA 
ABASEKWIMINYAKA YOKUFUMANA ABANTWANA 
 
ISIHLOKO SEPROJEKTHI ELUPHANDO:  
Ukuvavanywa kweenKqubo zeZongezelelo zezondlo neziJolise kuMaqela aHluphekayo 
eNtshona Koloni 
 
INOMBOLO SALATHISO: N07/10/232 
 
ABAPHANDI ABAPHAMBILI: 
UNjingalwazi uMarietjie Herselman, kwiCandelo lokutya okusiSondlo eMntwini, 
kwiYunivesithi yaseStellenbosch,  
UNjingalwazi Demetre Labadarios, kwiCandelo lokutya okusiSondlo eMntwini, 
kwiYunivesithi yaseStellenbosch, 
UNjingalwazi Per Ole Iversen, kwiCandelo lokutya okusiSondlo eMntwini, kwiYunivesithi 
yaseStellenbosch  
 
IDILESI: 
Division of Human Nutrition 
Faculty of Health Sciences, Stellenbosch University,  
Francie van Zijl Avenue,  
Tygerberg, 7505 
 
INOMBOLO YOQHAGAMSHELWANO: +27 21 938 9259 (UNjingalwazi uMarietjie 
Herselman) 
 
 Uyacelwa ukuba uthathe inxaxheba kwiprojekthi yophando. Nceda uthathe ixesha 
ukufunda ulwazi olubhalwe apha, oluza kucacisa ngeenkcukacha zale projekthi. 
Nceda ubuze abasebenzi besi sifundo nangayiphi na imibuzo ngale projekthi 
ongayiqondi ngokupheleleyo. Kubaluleke kakhulu ukuba waneliseke 
ngokupheleleyo ukuba ukuqonda ngokucacile okuqulathwe lolu phando nokuba 
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ungabandakanyeka njani. Kwakhona, ukuthatha kwakho inxaxheba 
akunyanzelekanga kwaphela kwaye uvumelekile ukuba ungala ukuthatha 
inxaxheba kolu phando. Ukuba uthi hayi, oku akuzi kukuchaphazela ngendlela 
embi. Ukwavumelekile ukurhoxa kwesi sifundo nanini na, nokuba ubuvumile 
ukuthatha inxaxheba. Zonke iinkcukacha ezinokwayamaniswa nawe, 
kubandakanywa ifomu yovavanyo neyesivumelwano ziza kugcinwa ziyimfihlo, 
kwaye akukho magama aza kusetyenziswa nakoluphi na uxwebhu olukwesi 
sifundo. Amalungu agunyazisiweyo eKomiti ejongene nophando ngokuziphatha 
ngokusesikweni anokuzibona iinkcukacha eziqokelelweyo ngexesha kusenziwa 
isifundo, phantsi kweemeko zokuba izinto ezilapha ziza kugcinwa ziyimfihlo, 
ngezizathu zolawulo olusemgangathweni naxa kusenziwa uhlolo kuphela xa 
kuyimfuneko. 
 
 Esi sifundo sivunywe yiKomiti ejongenenoPhando ngoMntu kwiYunivesithi 
yaseStellenbosch kwaye siza kwenziwa ngokwemigaqo yokuziphatha 
ngokusesikweninemimiselo yamazwe yesiBhengezo saseHelsinki, iMigaqo 
yaseMzantsi Afrika yokusebenza kakuhle ngamayeza neBhunga 
loPhandongaMayeza (iMRC) neMigaqo yokuziphatha ngokusesikweni kuPhando. 
 
INGABA ESI SIFUNDO SOPHANDO SINGANTONI NA? 
 
 Eyona njongo iphambili kukuvavanya iinkqubo ezisetyenziswayo ekongezeleleni  
izondlo kubantwana kunye noonina babo/iimpelesi, amakhosikazi asekwiminyaka 
yokufumana abantwana nakwabo baneTB kunye neHIV/AIDS. Kukho ithemba 
lokuba esi sifundo siyakunceda ekuphuculweni kwendlela ezisetyenziswa ngayo 
ezi nkqubo ukuze kuxhamle nabanye kwixesha elizayo. ZiiKlinikhi zeMpilo 
esisiSeko (Primary Health Clinics) ezili-100 ekuza kuqhutyelwa ezi zifundo 
kwiPhondo leNtshona Koloni.  
 Kwesi sifundo uza kubuzwa ngokuthabatha kwakho inxaxheba kwiinkqubo 
zokongezelela izondlo namava onawo. Ezinye izinto ezinokwenziwa, kukuthathwa 
komlinganiselo wobude/umphakamo, ubunzima kunye nesazingi 
sengalo/isinqe/amadywantsi. 
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KUNGASIZATHU SINI UKUBA UCELWE UKUBA THABATHA INXAXHEBA? 
 Ucelwe ukuba uthabathe inxaxheba kuba ungumama osekwiminyaka yokufumana 
abantwana kwaye uhamba iklinikhi kwelinye lamaziko achongelwe ukuqhuba esi 
sifundo. 
 
LUZA KUBA YINTONI UXANDUVA LWAKHO 
 Ukuba uyavuma ukuthabatha inxaxheba kwesi sifundo kuza kufuneka uthobele 
imyalelo yestafu malunga nokunika iimpendulo kuxwebhu lwemibuzo, umliganiso 
wobude/umphakamo, ubunzima bomzimba kunye nesazingi sengalo/isinqe/ 
amadywantsi, kunye nokutsalwa kwegazi. Nceda unyaniseke xa uphendula 
imibuzo ebuzwa sisitafu ukuze siqiniseke ukuba iziphumo zesi sifundo ziza 
kuchaneka.  
 
INGABA  UZA KUXHAMLA NGOKUTHABATHA INXAXHEBA KOLU PHANDO? 
 Ungangafumani nzuzo ikhawulezileyo ngokuthatha kwakho inxaxheba kwesi 
sifundo. Kanti ke, kukho ithemba lokuba ukuthatha kwakho inxaxheba kuza 
kuphucula iinkqubo zokongezelela izondlo nemeko yempilo kuluntu lwePhondo 
laseNtshona Koloni. 
 
INGABA BUKHONA UBUNGOZI ONOKUBUFUMANA XA UNOKUTHATHA 
INXAXHEBA KOLU PHANDO? 
 Hayi, emva kophando uza kuziphilela nje kakuhle akuyi kubuya kubekho nto iza 
kukhathazana nempilo yakho kwixesha elizayo. 
 
NGUBANI OZA KUBA NOLWAZI NGEENKCUKACHA ZONYANGO LWAKHO? 
 Ngabaphandi kuphela abaza kufikelela kwezo nkcukacha zakho ziqokelelweyo 
ngeli xesha kwenziwa esi sifundo, kwaye zonke iinkcukacha ziza kugcinwa 
ziyimfihlo. Ukuba ziza kusetyenziselwa upapasho okanye ithisisi, iinkcukacha 
ngawe ziza kugcinwa  ziyimfihlo.  
 
XA KUNOKWENZEKA ISEHLO ESINGAQHELEKANGA SOKWENZAKALA NGENXA 
YOKUTHATHA KWAKHO INXAXHEBA KWESI SIFUNDO SOPHANDO KUZA 
KUTHWANI? 
 Ukonzakala asinto inokufana ikwehlele kwesi sifundo  njengoko ukuqhutywa 
kwaso  kusekelwe ekunikeni iimpendulo zakho kumaxwebhu anemibuzo. 
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IYunivesithi yaseStellebosch ine-inshorensi evunyiweyo nelungiselwe ukuze 
ikhawulelane nento enokuthi ikwehlele ngexesha uphantsi kwesi sifundo.  
 
INGABA UZA KUHLAWULWA NGOKUTHABATHA KWAKHO INXAXHEBA KWESI 
SIFUNDO KWAYE ZIKHO  IINDLEKO EKULINDELEKE UKUBA UZIHLAWULE? 
 Akukho ntlawulo uza kuyifumana ngokuthatha inxaxheba kwezi zifundo kwaye 
akukho zindleko zikhoyo xa uthatha inxaxheba. Akusayi kucelwa ukuba uphinde 
uze eklinikhi kwakhona ngeenjongo zolu phando lunye. 
 
INGABA IKHONA ENYE INTO EKUFUNEKA UYAZI OKANYE UYENZE? 
 Ungaqhagamshelana naye namphi na umsebenzi oxeliweyo ngentla ukuba 
unemibuzo malunga nesifundo.  
 Ungaqhagamshelana neKomiti yoPhando ngoMntu kwa-021-938 9207 ukuba 
kukho izinto ofuna ukuziqonda okanye unezikhalazo ezingaqwalaselwanga 
ngokwaneleyo ngabasebenza kwesi sifundo. 
 Uza kufumana ikopi enezi nkcukacha nefomu yesivumelwano ukuba uzigcinele 
 
UMTHATHI-NXAXHEBA WAZISA PHANDLE 
Ngokutyikitya ngezantsi apha, Mna…………………………………..…………. ndiyavuma 
ukuthabatha inxaxheba kwisifundo sophando esihloko sithi “Uvavanyo lwamaSebe 
aChongiweyo kwiNkqubo eqhutyelwa kumaZiko eMpilo ekunikeni umzimba isondlo 
kwiPhondo leNtshona Koloni” 
Ndiyavuma ukuba: 
 
• Ndizifundile okanye ndizifundelwe iinkcukacha nefomu yemvume kwaye 
ibhalwe ngolwimi endilwaziyo nendiziva ndikhululekile ukulusebenzisa. 
• Ndibenalo ithuba lokubuza imibuzo kwaye yonke imibuzo yam iphendulwe 
ngokufanelekileyo 
• Ndiyakuqonda ukuba ukuthatha inxaxheba kwezi zifundo akunyanzelekanga 
kwaye khange ndifakelwe uxinzelelo ukuba ndithathe inxaxheba kwezi 
zifundo. 
• Ndingakhetha ukurhoxa kwezi zifundo nangaliphi na ixesha kwaye andizi 
kohlwaywa okanye ndidlelwe indlala nangayiphi na indlela. 
• Ndinokucelwa ukuba ndisishiye isifundo phambi kokuba sigqitywe ukuba 
abasebenzi besi sifundo babona ukuba oko kuya kundinceda, okanye ukuba 
andisilandeli isicwangciso njengoko kuvunyelwene.  
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Kutyikitywe (indawo) ......................…........…………….ngomhla we-…………....………..  
 
 ...................................................................   ................................................................. 
Ukutyikitya komthathi-nxaxheba ............. Ukutyikitya kwengqina 
 
UMPHANDI WAZISA PHANDLE 
Mna (igama) ……………………………………………..……… ndiyavuma ukuba: 
• Ndizicacisile iinkcukacha ezikolu xwebhu ku ………………………………….. 
• Ndimkhuthazile ukuba abuze imibuzo kwaye ndithathe ixesha elaneleyo 
ukuyiphendula 
• Ndanelisekile ukuba uyiqonda ngokufanelekileyo yonke imiba yophando, 
njengoko ichaziwe ngentla 
 Ndisebenzise/khange ndisebenzise toliki (ukuba kusetyenziswe itoliki, itoliki 
kufuneka ityikitye isivumelwano ngezantsi). 
 
Kutyikitywe (indawo) e......................…........…………… ngomhla we…………....………... 
 
 ...................................................................   ................................................................. 
Ukutyikitya komphandi Ukutyikitya kwengqina 
 
ITOLIKI YAZISA PHANDLE 
Mna (igama) ……………………………………………..……… ndiyavuma ukuba: 
• Ndimncedisile umphandi (igama)……….…………………………. ukucacisa  
iinkcukacha ezikolu xwebhu ku-(igama lomthathi-nxaxheba) 
……...………………………... ndisebenzisa ulwimi lwesiBhulu/Xhosa. 
• Simkhuthazile ukuba abuze imibuzo kwaye sithathe ixesha elaneleyo 
ukuyiphendula. 
• Nditolike okuchanekileyo ebendikuchazelwe. 
• Ndanelisekile ukuba umthathi-nxaxheba uwuqonda ngokupheleleyo umxholo 
wolu xwebhu lwemvume kwaye yonke imibuzo yakhe iphendulwe 
ngokwanelisayo. 
 
Kutyikitywe (indawo) e......................…........…………. ngomhla we…………....………..  
 ...................................................................   ................................................................. 
Ukutyikitya kwetoliki     Ukutyikitya kwengqina 
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APPENDIX H 
ETHICS APPROVAL FROM HEALTH RESEARCH ETHICS  
COMMITTEE OF STELLENBOSCH UNIVERSITY 
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